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Timing is the name of the game; a day too late or too 
soon and the endometrium is not receptive. A little 
be fore or a little beyond the blastocyst stage and the 
embryo cannot implant . Each event depends on the 
others , the whole orchestrated by the signals that 
flicker to and fro between embryo and mother . 
Klepper A. Commentary : The first days . 
British Journal of Obstetrics and 
Gynaecology . 
1983 ; 90 : 593-594 
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SUMMARY 
This thesis is an investigation of the endocrinological events in 
patients undergoing in-vitro fertilization (IVF) and is based on 
the IVF program that began in 1982 in Kandang Kerbau Hospital. 
The first 22 patients were either stimulated with clomiphene 
alone or were unstimulated (phase I :July 1982- May 1983); 
clomiphene citrate 150 mg/day for 5 days from day 2 . Ultrasound 
scans were done daily from day 8 . The subsequent 105 cycles were 
stimulated with a combination of clomiphene and hMG (phase II 
September 1 983 t o September 1985) . Clomiphene 100 mg/day was 
given from day 2 f o r 5 days . On day 6, hMG injections were given ; 
regime I was 1 ampoule daily from day 6 to 8 , while regime II was 
2 ampoules daily f or the same duration . From day 9 , the hMG 
dosage was dependen t on the plasma E2 . An ultrasound scan was 
d one only on day 9 . In both phases , urine was collected regularly 
after admission and LH values determined with Hi-Gonavis twice 
daily . In the absence of the LH surge , hCG was given based on E2 
or ultrasound parameters . Laparoscopy was done 24-26 hours from 
the onset of the LH surge , or 34-36 hours from the hCG injection . 
In phase I , the follicular mean plasma E2 level varied from 195 
pg/ml/follicle 7 days before laparoscopy to 633 pg/ml/follicle on 
the day of the laparoscopy in the clomiphene-treated patients , 
and from 87 pg /ml/follicle 7 days before laparoscopy to 473 
25 
pg/ml/follicle on the day of the laparoscopy in the unstimulated 
group. In phase II, there was no difference in the E2 response up 
to the day of laparoscopic egg recovery for the two regimes (mean 
of 589.9 pg/ml/follicle and 661.8 pg/ml/follicle for regimes I 
and II respectively). Spontaneous LH surge was observed in 4 of 9 
cases in regime I, and 6 of 10 cases in regime II. When hCG was 
given earlier at E2 of 500 pg/ml/follicle, there were sig-
nificantly (p<0.02) more pre-ovulatory oocytes (98.9%), compared 
with the group when hCG was given later (92.4%). However, fer-
tilization and cleavage was significantly less (p<O.OS) for the 
earlier group (46.2% and 63.9% respectively). When the Hi-Gonavis 
assay was checked with RIA, the false negative rate was 7.4%, 
while the false positive rate was 16.7%. In the false positive 
group, 65% of the eggs were mature, and these fertilised and 
cleaved. On the other hand, in the true positive group only 36% 
of the eggs were mature, and only 58% fertilised and cleaved. 
Daily ultrasound in phase I showed a significant correlation in 
follicular growth in clomiphene-induced patients with 1 and 2 
follicles (p<0.001 ), but there was no such correlation in 
unstimulated patients. Though there was no difference in E2 
levels in the luteal phase, there was a significantly higher 
plasma P in the progesterone supported group with spontaneous LH 
surge on days 10, 12 and 14. 
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CHAPTER 1: 
INTRODUCTION 
This thesis is an investigation of the endocrinological events in 
patients undergoing in-vitro fertilization (IVF). Such events are 
important because it forms the basis of management of the 
patients, leading to egg recoveries and finally pregnancies. The 
most critical is the quality of the egg, and, now increasingly 
so, the quality of the sperm. The egg is nutured over 10 to 14 
days of dynamic endocrine changes. Such changes can be followed 
from studies in peripheral blood, mainly designed to give a bet-
ter understanding of natural cycles. Since the use of ovulatory 
drugs (Gemzell, Diczfalusy, Tillinger, 1958; Kistner, 1966) there 
is a better understanding of stimulated cycles. In IVF, initially 
there was a debate of unstimulated versus stimulated cycles (see 
Trounson, Leeton, Wood et al, 1981 ), but it is now recognised 
that stimulated cycles give better pregnancy rates, mainly be-
cause of increased numbers of oocytes and consequently embryos 
replaced (Gronow, Martin, McBain et al, 1985). This in turn has 
lead to overstimulation (Jones 1984) to increase the number of 
eggs collected. However, not much is known of controlled over-
stimulation, which is different from hyperstimulation (Rabau, 
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David, Serr et al , 1967) . The purpose of this the sis is to try to 
shed some light in this area of ovarian stimulation in an IVF 
program. 
This thesis is based on the IVF program in the Department of 
Obstetrics & Gynaecology , National University of Singapore. An 
IVF program to help childless couples was started by the Depart-
ment of Obstetrics & Gynaecology in 1982 at the Kandang Kerbau 
Hospital, Hampshire Road. When the Department moved to the Na-
tional University Hospital in Kent Ridge in October 1985, the IVF 
program was then based in the newly formed Division of Reproduc-
tive Endocrinology . 
Over the years since the commencement of the IVF program, various 
superovulation regimes were used . At the Kandang Kerbau Hospital, 
the first 22 patients were either superovulated with clomiphene 
alone or were unstimulated. For convenience in presentation, this 
period shall be designated phase I in this study (July 1982 -May 
1983). The subsequent 100 patients (September 1983 to September 
1985) were superovulated with a combination of clomiphene and 
human menopausal gonadotropin (hMG) and this is represented as 
phase II . 
When the IVF program became based in the National University 
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Hospital (phase III), the superovulation regime was changed to a 
combination of h MG with purified follicl e -stimulating hormone 
(FSH). This r e gime was also used for the gamete intra-fallopia n 
transfer (GIFT) method of treatment of infertility which was a lso 
available to patients as part of the Department's comprehensive 
subfertility treatment program. 
The objective of this study was to evaluate the endocrinological 
data collected from the program while it was based at Kandang 
Kerbau Hospital (phases I & II) during the period 1982 - 1985. 
The thesis is presented in the following manner: 
1. Literature review. 
A review of the endocrine manipulation which has contributed 
to the superovulation normally practiced for IVF. 
2. Materials and methodology. 
This includes an analysis of patients, their indications, 
description of their stimulation, the egg recovery proce-
dure, a brief description of the fertilization and growth in 
vitro of the embryos, the embryo replacement, and finally 
the luteal phase management. 
29 
3. Singapore's first test-tube baby. 
A case presentation of our first success. 
4. Follicular phases of unstimulated and clomiphene-induced 
cycles. 
Comparison of E2 response in phase I cycles where the 
patients were either unstimulated or stimulated with 
clomiphene . 
5. Follicular phase of clomiphene-hMG stimulated cycles. 
Comparison of E2 response in two clomiphene-hMG regimes. 
6. Earlier administration of hCG . 
The effect of earlier administration of hCG on oocyte 
quality . 
7. Spontaneous LH surges . 
The use of Higonavis for detection of spontaneous LH surge. 
8 . The combination of ultrasound with E2 estimation to predict 
spontaneous LH surge. 
The effect of diminished ultrasound scanning frequency and 
daily E2 estimation on the ability to predict spontaneous LH 
surges . 
30 
9. Progesterone support in luteal phase . 
A randomised trial of luteal phase support with P. 
10. Conclusion. 
11. References. 
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CHAPTER 2 
LITERATURE REVIEW 
a) Endocrine relationships in normal ovulatory cycle s. 
b) Induction of ovulation. 
c) Overstimulation for in-vitro fertilization. 
d) Possible complications in overstimulation. 
SYNOPSIS 
Induction of ovulation is important in the treatment of female 
subfertility. Recent understanding in the neurophysiology of 
ovulation control has assisted in the therapy of anovulatory 
women. More rec~ntly, augmentation of ovulation is employed in 
ovulatory women in order to overstimulate them for the purpose of 
collection of extra eggs, especially in IVF. Drugs used for this 
purpose include clomiphene, gonadotropins and GnRH; most of them 
are used in combination. This literature review surveys the field 
of ovulatory control and its use for IVF. 
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INTRODUCTION 
Induction of ovulation is one of the major advances in the past 
few decades in the treatment of anovulatory infertility. There 
are 4 major indications for ovulation induction: 1) fertility in 
anovulatory infertile women; 2) timing of ovulation in ir-
regularly ovulating women who may also need insemination with 
donor semen; 3) increase in oocyte numbers and control of matura-
tion for IVF and gamete intra-fallopian transfer (GIFT); or 4) as 
a test for hypothalamo-pituitary-ovarian axis function. 
This survey shall be limited to the more recent development of 
augmentation of ovulation in ovulatory women in order to over-
stimulate them for the purpose of collection of extra eggs. Drugs 
used for this purpose include clomiphene, gonadotropins and GnRH; 
most of them are used in combination. These approach is used 
principly in the newer reproductive technologies, especially IVF, 
GIFT, and related areas such as freezing of embryos. 
ENDOCRINE INTERRELATIONSHIPS IN THE MENSTRUAL CYCLE. 
The hypothalamo-pituitary-ovarian (HPO) axis is the pathway in 
which the 3 essential organs in ovulation send their messages 
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(hormones) from one to another. This axis is finely-tuned and can 
be easily disturbed . The main hormones involved are from the 
hypothalamus (GnRH); the pituitary (gonadotropins- FSH and LH; 
PRL); and the ovary (steroids- E2 and P, and the protein-
inhibin) . 
GnRH is a decapeptide (Matsu, Baba, Nair et al, 1971) secreted by 
the nerve bodies found mainly in the supraoptic and prechiasmatic 
regions of the hypothalamus. Their axons descend into 1) 
lateral palisade zone of median eminence (majority), and 2) 
medial basal hypothalamus and mamillary area. The self-priming 
effects of GnRH comprise of GnRH pulses every 90 minutes in the 
follicular phase (Knobil and Wildt, 1982). Each pulse releases 
gonadotropins and increases their synthesis. The pattern of GnRH 
secretion, and not the amount of decapeptide, is of critical im-
portance (Knobil and Wildt, 1982). 
GnRH secretion is also influenced by estrogens. There are 2 types 
of such "feedback": 
1 ) Negative feedback - ovariectomy results in a rise in FSH and 
LH; oestrogens given to postmenopausal women result in 
lowering of FSH and LH levels. 
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2) Positive feedback which triggers ne ural and pituitary eve nts 
that accompany the pre -ovulatory surge of gonadotropin. 
This surge is due mainly to increased pituitary response , a s 
well as to increased hypothalamic secretions of GnRH. Hence, 
the positive feedback effects of E2 are exerted mainly at 
the pituitary gland ; hypothalamic GnRH secretion plays an 
obligatory but permissive role (Knobil and Wildt , 1982). 
The neurotransmitters of importance are dopamine (DA) and 
norepinephrine ( NE ). DA inhibits while NE facilitates GnRH 
secretion (McCann and Moss, 19 7 5) •• Less importantly, acetyl-
choline and gamma-aminobutyric acid (GABA ) stimulate , while 
serotinin inhibits . Elevated PRL stimulates DA secretion 
(Gudelsky , Simpkins , Mueller et al , 1976) , thus inhibiting GnRH 
release . 
Gonadotropin secretion is pulsatile, reflecting its pulsatile 
control from the hypothalamus ( Yen , Tsai , Naftolin et al , 1972) . 
The number of FSH and LH pulses increases during the first few 
days after menstruation , and remains at about once every 90 
minutes until after ovulation (Wildt, Schwilden, Wesner et al , 
1983 ). No significant change in pulse frequency occurs during 
this time , including the midcycle surge (Wildt , Schwilden , Wesner 
et al , 1983),thus supporting the view that the drama tic increase 
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in gonadotropin secretion is not dependent upon changes in the 
pattern of hypothalamic GnRH secretion (Knobil, 1980). However, 
as the follicular phase progre sses, the amplitude of LH pulses 
decreases; moreover, the FSH/LH ratio decreases as FSH decreases 
from 12-20 miu/ml in the beginning of the cycle to 4-8 miu/ml at 
mid-cycle while LH values remain between 8-12 miu/ml (Wildt, 
Schwilden, Wesner et al, 1983). In the luteal phase, there are 
dramatic changes in LH pulse frequency; there is a reduction in 
LH pulse frequency, but with considerably larger amplitudes 
(except for the LH surge). With the onset of menstruation, pulse 
frequency increases dramatically and this continues for the first 
few days of the follicular phase until a pulse frequency of 
about once every 90 minutes is reached (Wildt, Schwilden, Wesner 
et al, 1983). 
When gonadotropin levels are taken once daily through the 
menstrual cycle, they have a characteristic pattern. FSH in-
creases just before menses of the preceeding cycle, due to 
decreasing E2 levels. FSH rises up to 4 to 5 days into the fol-
licular phase, stimulating the primary pool of follicles. 
However, small amounts of LH seems to greatly enhance this 
stimulatory effect of FSH, and seems to be necessary for 
steroidogenesis (Jones, Ruehsen, Johanson et al, 1969; Midgley, 
Niswender, Ga y et al, 1971; Bertrand, Coleman, Crooke et al, 
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1972). As the follicles become activated, they secrete E2. Fol-
licular growth increases rapidly during the second week. As the 
E2 levels increase, there is a negative feedback onto the 
pituitary and hypothalamus which results in decreasing levels of 
FSH. The interaction between estrogen and FSH may be important 
in the selection of the dominant follicle (Fritz and Speroff, 
1983). The "ovulatory quota" of one egg can only be overridden 
with exogenous gonadotropin. The fall in FSH removes the support 
for other less developed follicles, which then undergo atresia. 
LH levels rise slowly during this period. When E2 reaches a 
critical value, it activates a positive feedback, which results 
in an LH surge. This surge lasts for 3 days, with the peak on 
the second day. The LH surge initiates luteinisation and causes 
ovulation by a mechanism presently unknown. 
Steroid production is dependent on the enzymes present in the 
preantral follicle, and the granulosa cells at this stage are 
able to synthesize all three classes of steroids, though in 
limited quantities (McNatty, Makris, DeGrazia et al, 1979). 
However, substantially more estrogens are produced than androgens 
or progestins, through the aromatisation of androgens. This 
aromatisation is induced through FSH, which also results in an 
increase in FSH receptors. Neither FSH or ·LH is usually detected 
in antral fluid unless their blood levels are elevated. LH is not 
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normally present in the follicular fluid until or just after the 
LH surge. If LH levels a r e prematurely ele vate d in plasma or 
follicular fluid, reductase activity is stimulated and there 
is elevated androgen levels r e sulting in decre ase in mitotic ac-
tivity of granulosa cells and degeneration. The thecal cells are 
also important as they produce androgens in response to LH. The 
androgens then diffuse into the granulosa cells and are 
aromatised to oestrogens through FSH-induction. This is known as 
the two-cell, two-gonadotropin concept of ovarian 
sterioidogenesis (Darrington and Armstrong, 1979). The follicular 
fluid concentration of E2 (absolute and relative to androgen) in-
creases in proportion to the activity of the granulosa cell 
aromatase system and is highest in the preovulatory follicle. 
Although many follicles undergo a certain amount of growth and 
development during the reproductive cycle, only a certain number 
eventually reaches the stage of ovulation, while the rest become 
atretic. Several concepts have been proposed to explain the 
process of atresla (Ryan, 1981 ). Even though all follicles are 
exposed to the same extraovarian regulators, eg FSH and LH, there 
are considerable differences in the micro-environment of in-
dividual follicles (Van Look and Baird, 1980; McNatty, Smith, 
Makris et al, 1979; Bomsel-Helmreich, 1983). Atresia is thought 
to be due to differences in aromatizing capacity, and may be 
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caused by different sensitivities of follicles towards 
gonadotropins. It has been suggested that none of the follicles 
present in the beginning of a menstrual cycle which has the 
potential to reach the pre-ovulatory stage will attain full 
maturation unless it has been exposed sufficiently to the action 
of FSH to pass a critical threshold (Hillier, Van Hall, van den 
Boogard et al, 1891 ). This "threshold" is apparently determined 
for each follicle by one or more variables such as (a) local vas-
cularization optimizing the accessibility of follicles to 
gonadotropins (Zeleznik, 1981 ), (b) the number of granulosa cells 
and/or gonadotropin receptors per cell which would determine a 
differential response to gonadotropins (McNatty, 1981 ), and (c) 
interfollicular levels of substances which modulate the actions 
of gonadotropins per se (Hillier, Van Hall, van den Boogard et 
al, 1891; Zeleznik, 1981). 
In addition to steroids, gonadotropins and GnRH-like intra-
ovarian substances, there are other non-steroidal factors present 
in the follicle which influence follicular development (Daume, 
Chari and Hillensjoe, 1984). These include 
inhibin/folliculostatin, oocyte maturation inhibitor (OMI), 
follicle-stimulating hormone-binding inhibitor (FSH-BI), 
luteinization inhibito (LI), and luteinization stimulator (LS). 
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Inhibin is a protein hormone believed to suppress FSH release 
from gonadotrophs (DeJong and Sharpe, 1976). Its s e cretion 
decreases as ovulation approaches; hence the removal of its in-
hibitory activity allows the mid-cycle surge of FSH ( Kimura , 
Katoh, Taya et al, 1983). There are 2 molecular species with in-
hibin activity in human follicular fluid, a large inhibin with a 
molecular weight of 23,000 daltons, and a small inhibin with a 
molecular weight of < 1000 daltons (Chari, Hopkinson, Daume et 
al, 1979). The large inhibin has been shown to inhibit GnRH 
secretion by the hypothalamus (Chari, Duraiswami, Daume et al, 
1981 ). Inhibin has also been implicated as a regulator of intra-
varian function, with exogenous inhibin resulting in induction of 
follicular atresia (Daume, Chari and Hillensjoe, 1984). In addi-
tion to suppression of FSH release, small inhibin is also capable 
of inhibiting secretion of P by rat and human granulosa cells as 
well as the maturation of rat oocytes (Hillensjoe, Chari, Magnus-
son et al, 1981). 
The oocyte maturation inhibitor (OMI) was assumed because the 
oocyte, under physiological conditions, does not undergo the 
maturation division before ovulation (Channing, Anderson, Hoover 
et al, 1982). OMI from porcine follicular fluid has been par-
tially purified, and appears to be a peptide with a molecular 
weight of less than 2000 (Tsafriri, Pomerantz and Channing, 
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1976). 
The follicle-stimulating hormone binding inhibitor (FSH-BI) was 
first described by Darga and Reichert (1978) which, at the ap-
propriate site is capable of inhibting the binding of its hormone 
to its receptor, thus regulating ovarian function. It is a small 
molecule, about 1200 daltons. It is also not unique to follicular 
fluid, having been described from serum and ascitic fluid 
(Reichert, Sanzo, Darga, 1979). 
As the follicle matures it gains a substance that enhances 
luteinization . <luteinizing stimulator, LS). Its stimulatory ac-
tions on granulosa cells include morphological maturation, 
progesterone and estrogen secretion, enhanced responsiveness to 
gonadotropins and activation of ornithin decarboxylase (Daume, 
Chari and Hillensjoe, 1984). 
On the other hand, there is in fluid from small follicles a fac-
tor that inhibits spontaneous luteinization of granulosa cells, P 
secretion, prostaglandin F2 secretion, and responsiveness to LH 
and FSH (Daume, Chari and Hillensjoe, 1984). This factor is 
called the luteinization inhibitor (LI). 
Receptors for FSH are present on granulosa cells and not thecal 
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cells. Their numbers increase with follicular growth through cell 
division for the number of receptors per cell remains constant. 
FSH stimulates formation of its own receptors, as well as LH 
receptors; it also increases cAMP levels and enhances ovarian 
steroidogenesis (Edwards, 1980). LH receptors appear late. In the 
preovulatory follicle, the LH surge results in a co-ordinated 
series of changes (Edwards, 1980). The endocrine changes that 
occur include decline in receptors and binding of LH, decrease in 
the production of thecal androgens, reduction in aromatization by 
granulosa cells, and stimulation of P synthesis by 
granulosa cells. Preovulatory changes induced by the LH surge 
also include synthesis of prostaglandins, glycosaminoglycans and 
proteases as well as resumption of meiosis in oocytes. While the 
above changes are ascribed to LH, FSH stimulates granulosa cells 
to synthesize plasminogen and mucin. Follicles become 
desensitised to LH a few hours after the surge. 
The mechanism of ovulation is obscure. Both FSH and LH stimulate 
prostaglandin synthesis by granulosa cells (Tsafriri, Lindner, 
Zor, et al, 1972). Furthermore, both gonadotropins and pros-
taglandins stimulate granulosa cells to secrete an activator that 
converts plasma-derived follicular plasminogen into plasmin, a 
protease that may be important in the dissolution of the lamina 
basalis during ovulation (Espey, 1974). The functional sig-
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nificance of ovarian contractility is uncertain, and it may not 
be required for ovulation (Espey, 1978). Increased intrafol-
licular pressure in precipitating follicular rupture is now 
thought to be unimportant. 
E2 falls 24 hrs before ovulation and is thought to be due to ac-
tivation of the delta-4 pathway in the granulosa cells by the LH 
surge from the delta-S pathway in the thecal cells (Edwards, 
1980); E2 then rises with P produced by the corpus luteum. The 
pre-ovulatory fall in E2 coincides with an increase in sen-
sitivity of the follicle to LH at mid-cycle (Zeleznik, Midgley 
and Reichert, 1974; Brown, 1978). LH is necessary for corpus 
luteum function (Van de Wiele, Bogumil, Dyrenfurth, et al, 1970). 
There are LH receptors in human corpora luteal tissue (Lee, 
Coulam, Jiang et al, 1973). 
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and conceive on placebo alone (Evans, 1975). 
1. Clomiphene citrate and other anti-estrogens 
Clomiphene citrate belongs to a group of steroid-like compounds 
called stilbenes, along with cyclofenil and tamoxifen, with 
ovulatory function (Taubert and Kuhl, 1986). The discovery of a 
nonsteroidal analogue of E2 , clomiphene citrate, that has a 
stimulatory effect on ovarian function was made by Kistner and 
Smith (1960) , and Greenblatt and co-workers (Greenblatt, Bar-
field, Jungck et al, 1961 ). Since then, treatment with clomiphene 
has probably helped more infertile women to conceive than any 
other infertility treatment . 
Clomiphene (as with cyclofenil and tamoxifen) are nonsteroidal 
agents that have a structural similarity to the potent estrogen 
diethylstilbestrol . Although these compunds are not steroids but 
triphenylethylenes, their steric configuration shows a remarkable 
structural similarity to E2 , and therefore enables binding to 
estrogen receptors (Taubert and Kuhl, 1986). The binding activity 
of clomiphene citrate to uterine estrogen receptors has been 
reported to be lower than that of E2 (Ruh and Ruh, 1974). 
Clomiphene citrate has not been found to exert any progesta-
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tional, androgenic or anti-androgenic biological activity (Owman 
and Hafez, 1980). 
E2 activity is related to binding of its cytoplasmic receptor. 
This results in an allosteric change of its receptor configura-
tion ("activation"), leading to dimerization of the estrogen 
receptor complex (Little, Szendro, Teran et al, 1975). This com-
plex is then rapidly translocated to the nucleus where it acts 
preferentially with a small number of specific binding sites on 
the genome, along with nonspecific interactions of the receptor 
protein with DNA (Yamamoto and Alberts, 1974). The only limiting 
factor is the amount of receptor available (Katzenellenbogen, 
Bhakoo, Ferguson et al, 1979). The gradual movement of the 
steroid receptor complex to the nucleus, and the maintenance of 
elevated levels of nuclear receptors for a longer period of time 
involves the depletion of cytoplasmic receptors for some hours 
(Chan and O'Malley, 1976). During this period the organ is insen-
sitive to additional hormone. Replenishment of the receptor (by 
de novo synthesis as well as recycling after dissociation from 
the nuclear sites) results in return of sensitivity. However, the 
longer an estrogen dissociates from the receptor 'complex, the 
longer is the duration of nuclear retention, and the greater the 
biological effect (Weichmann and Notides, 1980). The full 
sequence of estrogen response of a target cell requires a minimal 
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number of estrogen r e ceptor complexe s to be retained in the 
nucleus for s e v e ral hours. 
The estrogen antagonist, in contrast to E2 , is incapable of in-
ducing the adequate allosteric configuration of the receptor com-
plex, and therefore has a different nuclear interaction. However, 
the earlier events are normal, ie. it is complexed with the 
cytoplasmic estrogen receptor and is translocated to the nucleus. 
More importantly, anti-estrogen action results in the failure of 
replenishment of the depleted cytoplasmic receptor. Moreover: 
their dissociation from chromatin is impaired, and they remain in 
the nucleus for a longer period of time, blocking the recycling 
of receptors back to the cytoplasm (Katzenellenbogen, Bhakoo, 
Ferguson et al, 1979; Chan and O'Malley, 1976). Clomiphene 
citrate has been found to persist in body tissues up to 3 months 
(Trounson and Leeton, 1982). Therefore, clomiphene is an an-
tagonist not because it competes for cytoplasmic receptors, but 
because it maintains the depletion of cytoplasmic reeeptors, 
causing to a certain extent a state of estrogen-insensitivity of 
the target cell. 
The manne r in which ovulation is induce d by clomiphene is still 
uncertain, although it is very likely to be due to a reduction in 
the negative feedback of endogenous estrogens. The augmentation 
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of gonadotropin secretion has not been localized specifically to 
either a hypothalamic or pituitary event. It has been suggested 
that clomiphene citrate depletes estrogen receptors in the 
hypothalamus (Etgen, 1979; Kahwanago, Heinrichs and Herrmann, 
1970), stimulating GnRH release and a subsequent rise in LH and 
FSH (Miyake, Aono, Minnagawa et al, 1980). Alternatively, or con-
comitantly, clomiphene citrate may decrease the cytosol estrogen 
receptor content of pituitary cells, allowing an interruption of 
tonic gonadotropin suppression by estrogen (Etgen, 1979; Kah-
wanago, Heinrichs and Herrmann, 1970). 
When clomiphene is administered in the early follicular phase, an 
increase of LH, and to a much lesser degree of FSH, is seen 
(Vande nberg and Yen, 1973); this is suggestive of a decrease in 
the feedback inhibition of the hypothalamic-pituitary axis by E2 • 
This positive effect on LH is enhanced by administration of 
clomiphene during the late follicular phase, but it has no effect 
on gonadotropin secretion during the luteal phase (Vandenberg and 
Yen, 1973). 
The FSH elevation in response to clomiphene is thought to allow 
follicles other than the dominant follicle to become pre-
ovulatory by increasing the amount of FSH available to them. This 
results in a rapid stimulation of E2 production, and continues to 
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increase markedly after cessation of clomiphene ingestion until a 
maximum is reached the day before the pre-ovulatory LH surge 
(Vandenberg and Yen, 1973). However, this continuous increase in 
E2 production can occur independently of serum gonadotropin 
levels, suggesting a direct effect of anti-estrogens on the ovary 
(Groom and Griffiths, 1976). Adashi (1984) proposed that the pro-
fertility effect of clomiphene is due to the sum of direct ef-
fects on the hypothalamus, pituitary and ovaries. 
Besides the long-loop feedback regulation of the HPO axis, an in-
ternal short-loop feedback control within the follicles appears 
to be responsible for the individual hormonal "micro-climate" of 
the follicular fluid (Taubert and Kuhl, 1981 ). This is supported 
by in-vitro culture experiments on granulosa cells; Zhuang, 
Adashi and Hsueh (1981) have reported that clomiphene augmented 
the gonadotropin-stimulated estrogen production in cultured 
granulosa cells. This direct positive feedback of clomiphene 
could be responsible for the four-fold increase in estrogen con-
centration in follicular fluid during clomiphene treatment as 
compared to normal ovulatory cycles (Smith and Kistner, 1963). 
The marked rise in intra-follicular E2 level leads to a relative 
autonomy from gonadotropins of the maturing follicle until ovula-
tion. This could account for clomiphene-induced overstimulation 
of the ovary (Taubert and Dericks-Tan, 1976). On the other hand, 
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the direct action of clomiphene on the ovary can only take place 
when follicular development has reached a certain stage of 
maturation; this is seen clinically when clomiphene-induced , 
ovulation can only occur in normoestrogenic women. 
Clomiphene citrate is the first line treatment for amenorrhoeic 
and oligomenorrhoeic patients with normal FSH, LH and PRL levels. 
There are 2 stereo-isomers. The cis-form is an anti-estrogen and 
can produce ovulation in up to 78% of patients studied, while the 
trans-form is mildly estrogenic with an ovulation rate of 51% 
(Asch and Greenblatt, 1976). However, the preparation used 
Clinically contains both the cis- and trans-form, and induces 
ovualtion between 40 and 70%. Clomiphene acts on the hypothalamus 
and causes a rise in FSH and LH during its administration. This 
Stimulates follicular growth and a pre-ovulatory peak occurs 3-9 
days after completion of therapy (Jacobson, Marshall, Ross et al, 
1968). However, probably because of different sensitivities of 
the hypothalamic receptors to the positive and negative feedbacks 
Of estrogens produced by the ovaries, ovulatory responses differ 
and some patients remain anovulatory. 
Treatment regimes with clomiphene vary with centres. The most 
Common is with clomiphene from day 5 following for 5 days 
(Buppert, 1979). An alternative is from day 2 for 5 days. Some 
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centre$ prefer to go by the patients' cycle length. Dose starts 
from 50 mg daily and can be increased to 200 mg daily in 50 mg 
increments per cycle if anovulatory. Some patients may experience 
hot flushes at the higher dosages. 
Response with clomiphene is more likely in less severe forms of 
hypothalamic dysfunction. In a series of 283 patients, Brown and 
co-workers (Brown, Pepperell and Evan, 1980) reported 85.3% of 
Patients with anovulatory cycles ovulated, 74.0% of the 
oligomenorrhoeics, 56.3% of the patients with secondary amenor-
rhoea ovulated, and none of the patients with primary amenorrhoea 
ovulated. In the 3 groups that responded, the pregnancy rates 
are about half the ovulation rates. This low pregnancy rate has 
been ascribed to the anti-estrogenic effect of clomiphene on the 
cervical mucus. 
In an analysis of 1034 pregnancies after clomiphene therapy in 
Japan, Kurachi . and co-workers (Kurachi, Aono, Minagawa et al, 
19 83) reported a 2 .3 % visible malformations in the live-births. 
Abortion rate was 14.2% and stillbirth rate was 1.6%. There was 
also no correlation between the clomiphene dosage and malforma-
tion rate. Their conclusion was that clomiphene citrate does not 
give rise to an increased incidence of malformations. 
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Side-effects of clomiphene therapy include hot flushes (10.7 %) 
and pelvic discomfort (7.4 %). A small number of patients complain 
of visual disturbances a nd other vague symptoms . 
Complications of clomiphene therapy are related to ovarian hyper-
stimulation and consist of enlargement of the ovaries and mul-
tiple pregnancies . Multiple pregnancy can be expected in 10 %. 
Although the majority are twins ( 99 %) , triplets , quadruplets , 
quintuplets and even sextuplets have been reported . 
2 . Gonadotropins 
The pituitary gonadotropins FSH and LH , the placental 
gonadotropin hCG and thyroid stimulating hormone (TSH) are 
closely related in that they are glycoproteins made up of 2 dis-
similar subunits designated alpha and beta . The 2 subunits are 
linked by hydrophobic (noncovalent ) binding and can be dis-
sociated by treatment with 10M urea at pH 4 . 5 or 1 M propionic 
acid and highly purified . The pure subunits are practically 
without biological activity but the activity is regenerated by 
allowing the 2 subunits to recombine . 
Human FSH , hLH, hCG and hTSH have a common alpha subunit which 
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contains 92 amino-acids and two carbohydrate moieties. The beta 
subunits are different and provide the unique biological 
properties of the hormone. Nevertheless, portions of the beta 
polypeptide chain of one gonadotropin may be found in others. 
This is seen particularly in hLH and hCG where considerable 
homology in the polypeptide chain occurs, and these 2 
gonadotropins probably share common receptor sites. Some of the 
properties of the subunits of the gonadotropins are shown below: 
Number of Beta Beta Beta Beta 
FSH LH hCG TSH 
---------------
------ ------ ------ ------
amino acids 92 11 8 11 5 1 45 
carbohydrate groups 2 2 1 2 branched 
4 straight 
% carbohydrate 26 1 4 - 1 8 6 - 8 25 - 36 
average Mol. Wt 14,500 16,500 15,200 22,200 
The function of the carbohydrate moieties is still uncertain . 
They determine the biological half-lives of the hormones and 
therefore their biological activities in vivo, but they have 
little effect on in vitro assays . They contain sialic acid as im-
portant constituents . Differences in the sialic acid content ac-
count for differences in molecular weight of the hormone isolated 
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from different sources and differences in biological activity 
determined by in vivo assays (Brown, 1986). 
The FSH and LH circulating in the blood are different from the 
hormones extracted from the pituitary gland. Moreover, the 
pituitary produces gonadotropins of different molecular weight 
according to the physiological state of the animal; the FSH and 
LH extracted from the pituitaries of oophorectomized rhesus 
monkeys had larger average molecular weights and longer biologi-
cal half-lives than those obtained from intact females (Peckham 
and Knobil , 1976), attributed to changes in sialic acid content. 
Purified FSH has also been prepared from the urine of 
postmenopausal women, the specific activity being 1255 iu/mg 
(Donini, 1976). Its molecular weight is only 28,000 daltons, it 
has 208 aminoacids, and has a biological activity of 780 iu/gm; 
this is different from pituitary FSH with a molecular weight of 
41,000 daltons, and it has 254 aminoacids and its biological ac-
tivity is 14,000 iu/gm. The aminoacid content shows differences 
from FSH derived from other sources as well. However, the am-
nioacid sequence and attachment of the carbohydrate moieties have 
not yet been reported (Brown, 1986); this information is required 
for the understanding of the biological activity of hMG used in 
therapy. The urinary FSH has a higher hexose and a lower sialic 
54 
acid content than the pituitary hormone . Inspite its dis-
similarity with pituitary FSH , there is no clinically significant 
difference in ovarian stimulation when these preperations are 
given in biologically equivalent dosages (Schwartz and 
Jewelewicz , 1981 ) . 
The metabolic clearance rates (MCR) and serum half-lives of the 
gonadotropins have been studied by various groups . Because of the 
distribution of the hormones in more than 3 mathematical compart-
ments , it was difficult to determine the true half-life (Kohler , 
Ross and Odell , 1968 ; Coble, Kohler , Cargille et al , 1969) . The 
serum half-life of FSH has been reported at about 3 hours 
(Parlow , 1965) , of LH from 1/2 to 1 hour (Pepperell , deKretser 
and Burger , 1975), and of hCG from 5 - 8 hours (Rizkallah, Gur-
pide and Van de Wiele , 1969) . No figures could be found on the 
metabolic clearance rate and plasma half-lives of hMG prepara-
tions (Brown , 1986) . 
In contrast to treatment with clomiphene citrate (which requires 
an intact hypothalamus-pituitary) , treatment with gonadotropins 
is independent of these structures and provides the total 
stimulus to the ovaries . Nevertheless , the majority of 
anovulatory patients have normal FSH levels, and therapeutic 
supplementation is to complement endogenous production so that 
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the total dose reaches the patient 's threshold requirement for a 
follicular response . However , the dose requirement for FSH is 
critical, the difference between no-response and over-response 
being covered by a dose increment of less than 50%. Moreover, 
the dose required by different individuals may differ by 10-fold. 
This has resulted previously in frequent hyperstimulation and 
multiple pregnancies with inevitable fetal losses. Now, with 
step-wise increment of FSH from initial low doses and monitoring 
of ovarian response by blood or urine estrogens and ultrasound, 
such problems are less common. 
Gonadotropin therapy requires 2 gonadotropin preparations, one to 
supply FSH for follicular maturation, and the other to supply LH 
for inducing ovulation of the matured follicle. Preparations sup-
plying FSH include: 
1. Human menopausal gonadotropin (hMG) - this is the main commer-
cial source obtained from postmenopausal women's urine, and 
provides FSH:LH in the ratio of 1:1, each vial giving 75 
i.u. FSH. The commercial preparations include Pergonal 
(Serono) and Humegon (Organon). 
2. Purified human menopausal gonadotropin ("pure" FSH) - this has 
been recently introduced as Metrodin (Serono), and contains 
FSH:LH in the ratio of 100:1. 
3. Human pituitary gonadotropin (hPG) - this is obtained from 
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cadaveric human pituitaries, and at extraction growth hor-
mone is also obtained. The FSH:LH ratio varies from 1:1 to 
1 : 3 . Hence it is important to determine the exact ratio. 
Also the FSH concentration per vial may vary depe nding on 
the yield. 
4 . Pregnant mare ' s serum gonadotropin - contains largely FSH ac-
tivity but cannot be used repeatedly in the human because of 
antibody formation . However, it is preferred over hMG for 
hyperstimulation of laboratory animals. 
The LH preparation is hCG and is readily obtained from urine of 
pregnant women . hCG has a longer half-life than LH (see above) 
and is thus more economical for clinical use. 
It was initially believed that pure FSH given in the follicular 
phase does not promote sufficient steroidogenesis, and that the 
LH component is necessary for it . The use of pure FSH was ini-
tially confined to patients with polycycstic ovarian syndrome who 
have had normal or elevated levels of LH . However, only very 
recently has pure FSH been found to be able to stimulate the 
growth of good follicles (Bernadus , Jones, Acosta et al , 1984) . 
Hypogonadotrophic hypogonadal patients are the most suitable for 
gonadotropin therapy . Lunenfeld and Insler (1974) classified 
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such patients into 2 groups: group I - women with low basal 
gonadotropin levels and lack of endogenous activity (most of 
these patients have hypothalamic hypogonadotrophic hypogonadism); 
group II - women with low-normal or normal gonadotropin levels 
and evidence of estrogenic activity (most of these patients have 
hypothalamic-pituitary dysfunction and the polycystic ovary 
syndrome). 
There are many regimes available. Thompson and Hansen (1970) sum-
marized the various regimens: 
1. Daily hMG, with hCG overlapping hMG for the last 1-3 days, and 
sometimes continuing for 1 or 2 days after stopping hMG. 
2. Daily hMG, with hCG for 1 to 3 days starting 1 or 2 after hMG 
is stopped. 
3. hMG on days 1,4 and 8 followed by hCG on day 11. 
4. hMG alone. 
5. hMG in a single dose followed by hCG on day 11. 
6. hMG in combination with clomiphene. 
Most centres no~ use an individualized regimen, and have aban-
doned all other methods. The most widely used method is as fol-
lows. Patients with no evidence of estrogenic activity are 
started on 2 ampoules of hMG daily while those with estrogenic 
activity are given 1 ampoule daily for the first 6 to 8 days. 
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Urinary or blood estrogens are monitored daily and ultrasound 
scans done to determine the number and size of follicles . If 
there is no ovarian response the dose is increased by 1 or 2 am-
poules at variable intervals, from every day to once every 4 
days. Once there is a response the dose is maintained until fol-
licular maturation is attained. Ideally, follicular maturation is 
reached within 10 to 15 days of therapy. hCG is then given at 
doses between 3,000 to 10,000 iu after a variable "coasting" 
period ( Brown, 1978). The luteal phase may have hCG or progestin 
support. 
It is now evident that the reproductive hormones are secreted in 
a pulsatile manner (Lancet editorial, 1984). Hence it is logical 
to emulate the physiological patterns by pulsatile administration 
of gonadotropins. This method has been reported only recently (Ho 
Yuen, Pride and Sime, 1984) and experience with this approach has 
been limited compared to the pulsatile administration of GnRH. 
Yet another new approach in gonadotropin administration is the 
use of large doses of a GnRH analogue (eg. agonist Buserelin, 
Hoechst) before exogenous gonadotropin administration. This has 
been reported for patients with poor luteal phase, for which the 
GnRH analogue was started during the luteal phase prior to the 
treatment cycle (Fleming, Adam, Barlow et al, 1982), and for 
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patie nts with increased LH and androgen levels, for which the 
GnRH an~logue was administered 2-3 weeks prior to the treatment 
cycle (Fleming, Maxton, Hamilton et al, 1985) . 
Clomiphene may be combined with hMG . Clomiphene is given daily 
for 5 days either from day 2 or day 5. They are then continued on 
hMG for a variable period . With this regime there is a much 
higher chance of spontaneous LH surge (from 30 to 70% of cases). 
There may be advantages of anti-estrogenic effects of clomiphene 
especially against the high estrogenic levels caused by hMG . 
Conceptions per cycle vary from 8 to 30% (Schwartz and 
Jewelewicz , 1981 ) . Patients conceived vary from 16 to 60%. Out-
come of pregnancies include an overall abortion rate of 28% and 
an overall multiple pregnancy rate of 28%, mostly the result of 
multiple ovulations . 
The main complication of gonadotropin therapy is hyperstimula-
tion . Rabau, David, Serr et al (1967) classified ovarain 
response after gonadotropin therapy into 3 main clinical 
categories and 6 grades: 
Mild hyperstimulation: 
Grade 1: Consists only of laboratory findings of hyperstimulation 
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-estroge n levels above 150 ug/24 hrs and pregnanediol 
excretion above 10 mg/24 hrs. 
Grade 2: The above laboratory findings plus enlargement of 
ovaries; sometimes small cysts are palpable . 
Moderate hyperstimulation: 
Grade 3: In addition to above, abdominal distension is present. 
Grade 4: In addition to above, vomitting and/or diarrhoea is/are 
present. 
Severe hyperstimulation: 
Grade 5: In addition to above, ovarian cysts are large and 
ascites and/or hydrothorax are present. 
Grade 6: Marked hemoconcentration with increased blood viscosity 
may result in coagulation abnormalities. 
Increased capillary permeability is probably the pathogenetic 
mechanism of- severe hyperstimulation; the ascites is a tran-
sudate. The risk of hyperstimulation is related to the E2 level; 
however, if hCG administration is withheld, the hyperstimulation 
syndrome is prevented (Butler, 1969). It is interesting to note 
that in IVF , patients, inspite E2 reaching very high levels and 
hCG administration, hyperstimulation is uncommon; this may be 
probably due to the aspiration of follicles. Creation of 
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pne umoperitoneum ma y be a factor, in which case ultrasonic 
as pira tion may be non-protective insofar as hyperstimulation 
goe s. In our e xpe rience, in case s where the E2 l e vels were ex -
c e ssive (above 10,000 pg/ml) and follicl e s numerous (above 15 of 
a vera g e diameter more than 15 mrn), there has been post-re cover y 
a scite s and severe enlargement of ovari e s (unpublishe d data); 
there was no increase pre-disposition of ascites and ovarian e n-
largement in patients who had ultrasonic aspiration . The rapy with 
high FSH:LH ratio preparations causes l e ss ovarian hype rstimu l a -
tion (Crooke, Butt, Palmer et al, 1963); hence it is hope ful 
that pure FSH may minimise hype rstimulation. However, in our IVF 
and GIFT program such hyperstimulated cases were seen only with 
FSH : hMG stimulation; this was because it is with this regime that 
we had such high E2 values and large number of follicles. As 
these cases were in a later phase / series they were not include d 
in the analysis of data . Mild hyperstimulation was seen in 8 . 4 to 
23 % of treatment cycles , moderate hyperstimulation in 6 to 7%, 
and severe hyperstimulation in 0 . 8 to 2% of cycles (Schenker and 
Weinstein, 1978) . 
3 . Gonadotropin-releasing hormone (GnRH) 
GnRH is a linear decapeptide [(Pyro) Glu-His-Trp-Ser-Tyr-Gly-Leu-
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Arg-Pro-Gly-NH 2 ] which binds to the specific receptors in the 
Pituitary gonadotrophs . The binding sites for this hormone are 
located in the extracellular surface of the plasma membrane. The 
Peptide evidently binds to the receptors with the glyc ine 
re · Sl.due , which probably serves as a " spacer " to hold the more im-
Portant amino acids in the proper spatial relationship for inter-
action with receptor binding sites (Stewart , 1981 ). Fo llowing the 
hormone receptor binding , adenyl cyclase is activated , which in 
turn increases the amount of cyclic AMP (2nd messenger ). The ac-
tion of cyclic AMP on the synthesis of gonadotropins by pituitary 
Cells is believed to involve various enzymes , such as protein 
kinase which phosphorylates various proteins . Furthermore , the 
Ultimate and critical factor for the release of gonadotropins ap -
Pear to be an increase in intracellular calcium (Blankstein and 
Lunenfeld , 1986) . 
GnRH has a very short half-life , due to inactivation at the Gly-
Leu bond by brain enzymes (Marks and Stern , 1974 ). It is a single 
neurotransmitter responsible for the secretion of both FSH and LH 
(Schally , Arimura and Kastin, 1971 ) . Activation of GnRH-
containing neurons depends upon neurotransmitters and sex 
steroids; there are interactions between dopamine, 
norep· l.nerphrine and GnRH in the nerve terminals of the 
hypothalamic median eminence (Zuspan and Zuspan , 1973) . Gonadal 
63 
steroids alter the responsiveness of the pituitary to the action 
of GnRH. In the presence of low endogenous estrogens (early fol-
licular phase of the menstrual cycle) the administration of GnRH 
results in minimal rise of both FSH and LH, while in the presence 
of high estrogens (late follicular phase) LH increases sig-
nificantly while FSH increases only slighlty. These patterns in 
the late follicular phase are not surprising, since in adult 
women a higher dose of GnRH is required to effect FSH release 
than for LH release (Yen, Lasley, Wang et al, 1975). 
It was shown only recently by Belchertz, Plant, Nakat et al 
(1978) that pulsatile, not continuous, administration of GnRH was 
able to maintain pituitary gonadotropic function in rhesus 
monkeys which had their medio-basal hypothalamus ablated, thus 
abolishing their endogenous GnRH secretion. Hypothalamic amenor-
rhoea is considered as a defect of hypothalamic GnRH secretion. 
In women with severe hypothalamic amenorrhoea, pulsatile ad-
ministration of GnRH at a frequency of 90 minutes resulted in 
follicular maturation, ovulation and corpus luteum formation 
(Leyendecker, 1979; Leyendecker, Struve and Plotz, 1980). Amenor-
rhoea as a symptom merely reflects a level of hypothalamic im-
pairment within the pathophysiological entity of hypothalamic 
ovarian failure . Depending on the reduction of hypothalamic GnRH 
secretion, clinical pictures such as corpus luteum insufficiency, 
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anovulatory cycles, oligomenorrhoea, and finally, amenorrhoea may 
develop . Hence , corpus luteum insufficiency and anovulatory 
cycles develop when an insufficient dose of pulsatile GnRH is 
used to treat hypothalamic amenorrhoea (Leyendecker and Wildt, 
1983). Secondary hypothalamic amenorrhoea is probably the result 
of the reduction of a pre-existing GnRH secretion and, func-
tionally, a relapse of the pituitary-ovarian axis into the pre-
menarchal state. This is often associated with more or less overt 
psychologenic or emotional stress (Fries and Nillius, 1973). En-
dogenous GnRH cannot be measured in peripheral blood and there-
fore direct evaluation of hypothalamic function is presently not 
possible and the diagnosis of hypothalamic amenorrhoea is essen-
tially based on the exclusion of other causes of amenorrheoa, eg. 
hyperprolactinemia, hyperandrogenaemia, primary ovarian failure, 
genital tract defects, general systemic and neurological dis-
eases. 
Leyendecker and Wildt (1983) proposed the following grading of 
hypothalamic amenorrhoea on the basis of clomiphene, progestagen 
and GnRH tests: 
Grade 1: A positive clomiphene test with menses after 100 mg/day 
for 5 days from the 5th day after withdrawal bleed to 
progestagen, indicates that there is only little impairment 
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of hypothalamic function . This is further sub-classified 
into : 1a) with normal luteal phase , 
1b) with insufficient luteal phase , 
1c) with anovulatory cycle . 
Grade 2 : Intermediate severity of hypothalamic amenorrhoea in 
which patients have progestagen-induced withdrawal bleed but 
do no t bleed after clomiphene . 
Grade 3 : Severe hypothalamic amenorrhoeic patients who do not 
respond to progestagen withdrawal . They have differing 
response to a bolus dose of GnRH ( 100 ug }, and are further 
subdivided into : 
3a) "adult response " in which the increase of 
plasma/serum LH is more than FSH ; 
3b) " prepubertal response " i n which the LH increase is 
impaired and is quantitatively and qualitatively 
similar to FSH ; 
3c ) no response to GnRH , the most severe form of 
hypothalamic amenorrhoea . 
The dose of GnRH is dependent on the degree of hypothalamic 
amenorrhoea . Thus patients with grades 2 , 3a and 3b dysfunction 
ovulate and conceive with 2 . 5 - 5 ug/pulse , while patients with 
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grade 3c dysfunction need 15-20 ug/pulse before ovulating and 
conceiving. Individual and uncontrollable factors influencing the 
resorption of the hormone from the adipose tissue, however, 
reduce the ovulation rate when the subcutaneous route is chosen. 
This disadvantage can be overcome by increasing the dose to 15 -
20 ug/pulse for grades 2, 3a and 3b dysfunction with the sub-
cutaneous route as used by most centres now. 
Once the critical threshold of the GnRH dose is surpassed there 
seems to be a dose-response relationship between the dose of GnRH 
administered per pulse and the ovarian response, as reflected by 
E2 and P response (Leyendecker and Wildt, 1983). Also, the dura-
tion of the follicular phase after pulsatile administration of 
GnRH is a reflection of the ovarian functional status at the 
beginning of the GnRH substitution. The average length of the 
follicular phase was 17 days in grade 3c, 14 days in grade 3b, 10 
days in grade 3a and 9 days in grade 2 of hypothalamic amenor-
rhoea. 
Decreasing the frequency of GnRH administration results in in-
creased FSH and decreased LH plasma concentrations, thus affect-
ing the FSH/LH ratio (Wildt, Hausler, Marshall, 1981). On the 
other hand, changes in amplitude of GnRH pulses have but minor 
effect on gonadotropin secretion (Wildt, Hausler, Marshall, 
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1981 ). However, in patients with enhanced pituitary sensitivity, 
ovarian hyperstimulation may occur (Schweditsch, Keller, Floer-
sheim et al, 1984). 
The normal luteotrophic hormone in the human is pituitary LH (Van 
de Wiele, Bogumil, Dyrenfurth et al , 1970). In severe 
hypothalamic amenorrhoea luteal function immediately ceases fol-
lowing termination of pulsatile GnRH substitution a few days 
after ovulation (Leyendecker and Wildt , 1983) . Continuation of 
pulsatile GnRH during the whole luteal phase resulted in normal 
luteal phase . The luteal phase may also be supported by 1-3 in-
jections of 2500 iu of hCG once ovulation has occurred 
(Weinstein, Seibel and Taymor , 1984 ). 
GnRH can also be administered at 10 ug/pulse to normally cycling 
women to induc e multiple follicular development (Liu , Durfee, 
Muse et al , 1983) . 
OVERSTIMULATION FOR IN-VITRO FERTILIZATION 
1. Principle 
The unifying goal of pregnancy underlies diverse strategies to 
monitor and/or control the ovulatory cycles of women undergoing 
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IVF and ET. This goal requires e ither stringent surveillance of 
an unperturbed spontaneous follicular phase, or hormonal regula-
tion of the cohort. Edwards, Steptoe and Purdy (1980) credited 
their change from stimulated cycles to spontaneous cycles as the 
major breakthrough responsible for their first (Steptoe and Ed-
wards, 1978) and subsequent pregnancies. They cautioned about the 
derangements of follicular steroidogenesis caused by ovarian hy-
perstimulation (Edwards and Steptoe, 1975). However, Trounson, 
Leeton, Wood, et al (1981) and Johnston, Lopata, Speirs et al 
(1981) proved that clomiphene citrate given daily from days 5 
through 9 of the menstrual cycle within an IVF program could 
result in viable pregnancies. 
The rationale of inducing maturation of several follicles for an 
IVF cycle is to maximise the number of recoverable oocytes. Most 
centres have successful retrieval of about 60 - 80% of follicles 
aspirated (Jonhnston, Lopata, Speirs et al, 1981; Renou, Troun-
son, Wood et al, 1981; Quigley, Wolf, Makland et al, 1982). Be-
tween 60 and 80% of these oocytes are fertilized, depending on 
the series and indications (Edwards, Fischel, Cohen et al, 1984; 
Mahadevan, Trounson and Leeton, 1983). However, less than 15% of 
these concepti result in implantations (Yovich, Stanger, Yovich 
et al, 1984a; Ng, Edirisinghe, Wong et al, 1986), and the recog-
nizable pregnancy rate is less than 20% . However, increasing the 
69 
number of embryos replaced increases the chance of pregnancy 
(Speirs, Lopata, Gronow et al, 1983; Jones, Acosta , Garcia et al, 
1983; Edwards , 1985; Seppala, 1985). Trounson (1983) noted a 
threefold increase in pregnancy rate when 2 embryos , rather than 
a single embryo , are replaced. Although the transfer of 3 or 4 
embryos may enhance the pregnancy rate, there is an increase in 
the risk of multiple pregnancies (Biggers , 1981; Kerin, Warnes , 
Quinn et al, 1983b). It has been calculated that 2.5 accessible 
15 mrn follicles are necessary to ensure , on the average, transfer 
of 1 embryo to each patient (Quigley, Wolf, Makland et al, 1982); 
in fact , the authors recommended that patients with only one 
developing accessible follicle not undergo oocyte recovery during 
that cycle. With that policy, they have reported that when 
clomiphene citrate was used for follicular stimulation, only 4 of 
96 patients (4.2 %) had the laparoscopy postponed (Quigley, Mak-
land and Wolf, 1983). 
In principle the achievement of high FSH levels during the early 
follicular phase to recruit a maximum number of follicles with a 
tolerable degree of asynchrony for final maturation is confined 
to a limited time span of "FSH window" of about 3 to 4 days 
before negative estradiol feedback induces below-threshold FSH 
levels, thereby condemning all subsequent follicles in that cycle 
to atresia (Kerin, Warnes, Quinn et al, 1984). It appears that 
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one can widen and/or amplify the "FSH window" too far from gross 
hyperstimulation resulting in the recruitment of many follicles 
with an intolerable degree of asynchrony. This may lead to defec-
tive e ndocrine environment for the oocytes contained within these 
follicles or an abnormal luteal environment and an increase 
frequency of failure in fertilization, cleavage and implantation 
(Kerin, Warnes, Quinn et al, 1984). 
2. Clomiphene 
The earliest attempts in an IVF program to stimulate follicular 
development with clomiphene citrate and to effect oocyte matura-
tion with hCG did not result in normal pregnancies . Edwards and 
Steptoe (1975) found no evid~nce of implantation in patients un-
dergoing IVF after receiving clomiphene citrate at 100 mg/day 
from day 2 or 3 for 5 days, and 5,000 iu of hCG intra-muscularly 
on day 12 or 13 . In another group of 27 patients treated with 50 
to 100 mg clomiphene citrate for 5 days from days 3 to 11, 2 
patients had a transient post-ER rise in hCG (Lopata, Brown, 
Leeton et al , 1978). In 1981, the Monash group (Trounson , Leeton, 
Wood et al, 1981) proved that clomiphene citrate could be used 
with good results in IVF when they reported 4 pregnancies induced 
with clomiphene , given at 150 mg daily from days 5 through 9. In 
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3 of the 4 women who became pregnant, 4000 iu of hCG was given 36 
hours before laparosocpy predetermined by "follicle growth rate 
and availablity of the operating room " (Trounson, Leeton , Wood et 
al, 1981 ). In a later report on 9 pregnancies induced with 
clomiphene citrate, 7 of these pregnancies (including 2 sets of 
twins) had progressed to between 16 and 31 weeks , while 2 aborted 
at 8 weeks (Wood , Trounson, Leeton et al, 1981 ). Other early 
reports of pregnancies induced with clomiphene supported the use 
of clomiphene in IVF (Johnston , Lopata , Speirs et al , 1981 ) . 
The maturational status of the retrieved oocyte in clomiphene-hCG 
stimulated cycles has been compared to that obtained during the 
monitored spontaneous cycle . The scheduling of laparoscopic 
oocyte recovery approximately 36 hours after hCG injection 
reduces the occurence of pre-operative ovulation (Edwards and 
Steptoe , 1 975 ) but may do so at the expense of invivo maturation . 
However , the recovery of mature , pre-ovulatory oocytes with 
cumulus masses indistinguisahble from mature oocytes recovered in 
spontaneous cycles (Wood , Trounson , Leeton et al , 1981) argues 
for maintaining this hCG-laparoscopy interval . At laparoscopy , 
pre-ovulatory follicles in clomiphene-stimulated cycles appear 
identical to those in spontaneous cycles , with features suggest-
ive of imminent ovulation (Wood , Trounson, Leeton et al, 1981 ) . 
Testart , Frydman , De Mouzon et al ( 1983) that the average number 
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of retreive d oocytes with fully expanded, homologous cumulus 
masses did not differ significantly between spontaneous and 
clomiphene-stimulated cycles. However , there was an increase in 
the number of fertilizable , though less mature, oocytes exhibit-
ing limited expansion of a heterogenous, granular cumulus in the 
stimulated cycles (Testart, Frydman, De Mouzon et al, 1983). 
Trounson and Leeton (1982) noted several disturbing anomalies in 
a small number of patients undergoing IVF who had clomiphene 
citrate. Some patients developed large cystic follicles which 
averaged approximately 3 em in diameter and lacked a normal 
oocyte and normal granulosa cells; such follicles were already 
atretic before aspiration. Other patients experienced premature 
ovulation or lengthened follicular phases. However, those 
patients who had laparoscopic aspiration of follicles did not ex-
hibit short luteal phases even though they were not supplemented 
with P. Normal luteal function in clomiphene-treated women under-
going follicular aspiration has been documented by Trotnow, Be-
cker, Kniewald et al (1982) by monitoring BBT charts and plasma P 
levels. 
Data of steroid concentrations from follicles in clomiphene-
stimulated cycles has been confusing. Carson, Trounson and 
Findlay (1982) found that follicles from which oocytes were 
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retrieved contained significantly higher concentrations of both 
E2 and P compared with those from which no oocytes were found . 
Normal embryo growth following IVF was associated with sig-
nificantly elevated levels of androstenedione, P and E2 , while 
pregnancy was correlated with significantly higher levels of E2 • 
They found that only follicles with high P levels produced heal-
thy, fertilizable oocytes. Another group of workers also corre-
lated in spontaneous cycles fertilizability of collected oocytes 
with high follicular concentrations of E2 and P (Wramsby, Kul-
lander, Liedholm et al, 1981 ). Testart, Frydman, Castanier et al 
(1983) also reported on follicular fluid steroids in spontaneous 
and clomiphene-stimulated cycles. Treatment with 100 to 150 mg 
clomiphene on days 5 through 9 reduced the proportion of fol-
licles with normal steroid concentrations. Most of the abnormal 
follicles had high androgens or low P concentrations. They also 
found that in spontaneous cycles, the success rate in IVF was not 
significantly influenced by follicular steroid levels provided 
minimum values were achieved; this was in contrast to the find-
ings of Wramsby , Kullander, Liedholm et al, (1981). Based on 
these conflicting findings, follicular fluid steroid concentra-
tions may not be predictive of the outcome of either spontaneous 
or clomiphene-stimulated cycles in IVF. 
Follicular fluid concentrations of gonadotropins also do not of-
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fer any predictive value in IVF outcome . Testart, Frydman, Cas-
tanier et al (1983) noted FSH values~ 0 . 3 miU/ml in all the pre-
ovulatory follicles aspirated during spontaneous cycles, compared 
with only 75.9% of clomiphene-stimulated (and hMG) cycles . The 
FSH concentration did not influence the dissociation of cumulus 
(Testart , Frydman, De Mouzon et al , 1983) . 
There is also the question of dosage . Trounson and Leeton (1981) 
reported that 50 mg clomiphene citrate administered daily on days 
5 through 9 did not produce more than 1 large follicle. However , 
in a study comparing clomiphene 50 mg and 150 mg / day from day 5 
through 9, Quigley, Makland and Wolf (1983) reported that there 
was no statistical differences in the number or size of follicles 
as determined by ultrasound on the day of hCG administration be-
tween the 2 groups . The mean number of f9llicles was 2 . 3 +-0 . 1 
in the 50 mg group and 2 . 4 +- 0 . 2 in the 150 mg group . There was 
no difference in oocyte recovery and their outcome between the 2 
groups (Schmidt , 1984 ) , and in greater than 90% of all treatment 
cycles, patients underwent laparoscopy . The oocyte recovery rate 
was around 60% , with the fertilization rate around 70% and the 
cleavage rate around 95% . The only statistical difference was the 
higher clinical pregnancy rate in the 50 mg clomiphene group 
(19 . 4% per ER) as opposed to none in the 150 mg clomiphene group. 
This study illustrates the possible negative outcome in increas-
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ing the ovulatory stimulation. 
Fixed schedules with clomiphene have been used to collect oocytes 
for research purposes from volunteers requesting laparoscopic 
sterilization (Braude, Bright, Douglas e~ al , 1984 ; Templeton, 
Van Look , Lumsden et al , 1984 ; Messinis , Templeton, Angell et al, 
1986) . The various authors used varying doses and duration of 
clomiphene to induce multiple follicular development , and Mes-
sinis , Templeton , Angell et al (1986) reported that there was no 
difference in the number of oocytes collected with clomiphene ad-
ministered at 50 mg and 150 mg daily for 5 days and 50 mg daily 
for 10 days . The patients were admitted on day 16 and 1400 iu of 
hCG was administered at 0200 hours on day 17 . The laparoscopy was 
arranged for midday on day 18 (around 34 hours after the hCG) . 
Oocytes were recovered from 83% of the aspirated follicles ( 1 . 6 
oocytes/patient ); 65% of the oocytes cleaved after IVF and, on 
the average , 1 . 0 cleaving egg was obtained per patient . However , 
as there were no embryo replacements and therefore no preg-
nancies , it was not possible to comment whether the oocytes or 
embryos obtained were developmentally normal . 
When the patient had only one ovary , clomiphene stimulation 
res ulted in a higher initial E2 level and a greater number of 
follicles >15 mrn , but there was no difference in the number of 
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oocytes collected from patients with one or two ovaries (Diamond , 
Wentz , Herbert et al, 1984) . The authors also reported on 
similar findings with hMG stimulation , but the number of oocytes 
collected were more from patients with 2 ovaries. In another 
study comparing response from patients with one or two ovaries, 
stimulation with c lomiphene-hMG did not result in any difference 
in mean number of follicles ~15 mm , oocytes collected, embryos 
transferred and resulting pregnancies (Alper , Seibel , Oskowitz et 
al, 1985) . 
Finally , there is the question of brand , or make , of the 
clomiphene . Diamond , Herbert , Maxson et al ( 1986) compared 
clomiphene from Merrell Dow (Clomid) and from Serono (Serophene) 
using the same dosage 150 mg/day from day 3 through 7 . The only 
difference detected in response was a greater elevation in E2 
levels with Clomid ; no differences were detected in laparos-
copies , eggs recovered, fertilization and embryo development . 
3 . hMG ! other gonadotropins 
The initiation of follicular growth is thought to be dependent on 
factors in addition to gonadotropins (Schmidt , 1984 ). However , 
FSH is essential to : (1 ) increase the number of granulosa cells; 
(2) increase the number of FSH and later LH receptors on 
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granulosa cells; and (3) increase the aromatase activity of these 
granulosa cells. The main purpose of FSH is to stimulate fol-
licular growth to the pre-ovulatory stage and to facilitate con-
version from an androgenic to an estrogenic follicular environ-
ment (Beauchamp, 1984). 
The mechanism determining follicular selection and atresia may be 
influenced by altering the gonadotropin patterns of the menstrual 
cycle. By preventing the decline in FSH (or actually increasing 
its level) while follicular selection and dominance is occurring, 
several extra follicles may be rescued from atresia and go on to 
develop to the pre-ovulatory stage. These increased gonadotropin 
levels my be accomplished directly with hMG administration or in-
directly by clomiphene citrate or GnRH administration. 
Ovarian response to hMG administration is monitored by clinical, 
ultrasonographic and laboratory methods. The size of pre-
ovulatory follicles, as determined by ultrasound, is smaller with 
hMG stimulation when compared to clomiphene-stimulated or natural 
cycles (Renaud , Macler, Ehret, et al, 1983; Mantzavinos, Garcia 
and Jones, 1983; Buttery, Trounson, McMaster et al, 1983). A ma-
ture, fertilizable oocyte can usually be obtained from 15-17 rnm 
diameter follicles during hMG stimulation (Garcia, Jones, Acosta 
e t al, 1983). In clomiphene stimulated or natural cycles, mature 
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oocytes are usually obtained only from follicles ~20 mm in 
diameter . Possible explanations for this discrepancy are either 
(a) inhibition of endogenous LH by hMG; (b) inhibition of fol-
licular growth by a fixed FSH/LH ratio during hMG therapy; (c) 
accelerated oocyte maturation with hMG; or (d) decreased number 
of granulosa cells or follicular fluid volume with hMG 
( Beauchamp , 1984). 
The circulating levels of E2 are derived primarily from develop-
ing follicles (Fritz and Speroff, 1982). Measurements of serum or 
urinary E2 concentrations have been utilized to monitor fol-
licular development in patients undergoing ovulation induction. 
Studies have shown that, during hMG stimulation, plasma E2 levels 
correlated well with total follicular volume (Haning, Austin, 
Kuzma et al, 1982). It was also reported that in hMG-stimulated 
cycles, there were significantly elevated E2 levels in follicular 
fluid from women who subsequently became pregnant (Botero-Ruiz, 
Laufer , deCherney et al , 1984). Three patterns of estrogen 
response to hMG stimulation have been identified: low, normal, 
and high estradiol responses corresponding to E2 levels of < 300, 
300-600, > 600 pg/ml respectively (Jones, Acosta, Andrews et al, 
1983). 
Studies on anovulatory women undergoing ovulation induction with 
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hMG show that the duration of the active phase of follicular 
maturation and the rate of exponential E2 rise may be as impor-
tant as absolute E2 levels in determining normalcy of the luteal 
phase, conception and multiple pregnancy rates (Berquist, Nillius 
and Wide , 1983a & 1983b). Even though the ovulatory dose of hCG 
was given at a standard E2 level (2000 pmol/1), a short active 
phase {7 days from baseline to threshold levels) was associated 
with a defective luteal pha?e of anovulation. Furthemore, concep-
tual cycles were associated with lower E2 levels during the fol-
licular phase and higher P levels during the luteal phase. It ap-
pears that rapid follicular development by hMG (as evidenced by 
rapid E2 rise), results in lower pregnancy rates and abnormal 
luteal phases probably due to ovulation of submature oocytes or 
abnormal corpus luteum formation (Yuen, Sy and Cannon, 1981 ). 
buration of the hMG administration to anovulatory women (number 
of days necessary to increase E2 from baseline to threshold 
levels) may also influence follicular recruitment. Singleton 
pregnancies were associated with treatments of <7 days duration 
while multiple pregnancies had longer (8-10 days) active phases. 
~t appears that the longer ovarian exposure to hMG predisposes it 
to multiple follicular development (Berquist, Nillius and Wide, 
1 983a) . 
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The ovarian response to hMG depends on at least 2 factors: the 
amount of gonadotropins administered and the state of the fol-
licles at the beginning of therapy (Insler and Potashnik, 1983). 
Each patient appears to have her own sensitivity to hMG, account-
ing for the variation observed in E2 response and in follicular 
development. 
hMG has been used alone for follicular recruitment in IVF 
programs; this has been pioneered mainly by the Eastern Virginia 
Medical School. Initially they used a protocol similar to that 
used for induction of ovulation (Garcia , Jones, Acosta et al, 
1983a). Two ampoules of hMG (150 iu FSH and 150 iu LH) was ad-
ministered starting on the first, third or fifth day of the cycle 
depending on cycle length, < 25 days, 25-35 days, or > 35 days, 
respectively. After 3 days of treatment, the dose was lowered to 
1 ampoule of hMG daily. With the appearance of the "estrogen 
clinical shift" (defined as >30% superficial cells on vaginal 
cytology, cervical mucus volume ~0.2 ml, spinnbarkeit ~10 em, 
and 4+ ferning), hMG was discontinued and 10,000 iu hCG was ad-
ministered 2-3 days later, depending on when the largest follicle 
reached 18 mm in diameter as determined by ultrasound. There was 
no endogenous LH surge in this study. Oocytes were recovered from 
all patients except one (31 cycles in 25 patients) with 60 
oocytes recovered in all (1.94 oocytes/cycle). Eighty% of those 
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oocytes were pre-ovulatory, 15% were immature and 5% atretic. 
Only 16 of the 48 (33%) pre-ovulatory oocytes fertilized and 
cleaved, and 2 pregnancies resulted from embryos transferred to 
12 patients (Wortham, Veeck, Witmyer et al, 1983). 
During the second phase (II) of their program, the hMG protocol 
was individualized according to the estrogen level at the time of 
the clinical estrogen shift (Garcia, Jones , Acosta et al , 1983b). 
Two ampoules of hMG were administered starting on the third or 
fifth day in patients who had 28 +3 and 35 +3 days cycles, 
respectively . Further management was based on serum E2 levels and 
the occurence of the " clinical shift". For low responders (E2 < 
300 pg/ml on the day of the clinical shift) hMG was continued for 
3 additional days after the shift . In the normal E2 responders 
(E2 300 - 600 pg/ml ) hMG was discontinued if the shift had oc -
curred . In the high estrogen responders , · hMG was discontinued 
once the E2 exceeded 600 pg/ml , even if the clinical estrogen 
shift had not occurred. The ovulatory dose of hCG (10,000 iu) was 
administered 50 hours after the last hMG injection (Jones, Jones, 
Andrews et al, 1982). A normal E 2 response was observed in 17 
patients , 3 patients had a low and 4 had a high E2 response . 
These 24 patients underwent laparoscopy . No oocytes were obtained 
in 1 patient and only immature oocytes were obtained in another . 
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Nine ty-eight follicles were aspirated (4.1 follicles per patient) 
and 57 oocytes were recovered (2 . 4 oocytes per patient) . Forty 
oocytes were mature (70%) . One patient had one follicle ruptured 
prior to laparoscopy but mature oocytes were recovered from other 
follicles . Of the mature oocytes 30 out of 33 fertilized and 
cleaved ; 7 of 10 immature oocytes matured in vitro , fertilized 
and cleaved . Five pregnancies resulted after transfer of 37 
embryos to 19 patients . 
Besides an overall improvement in outcome , there were 2 dif-
ferences between phases I and II . First , oocyte post - maturity 
(aging) was observed in 7 patients during phase I . Fragmentation 
of the oocytes and darkening of granulosa cells ( lipid inclusions 
from excessive luteinization ) were observed , most frequently in 
high responders . This observation was attributed to the result of 
prolonged hMG stimulation and failure of the E2 from the develop-
ing follicles to elicit an endogenous LH surge . Post-maturity was 
decreased by shortening the duration of hMG therapy and by short-
ening the interval from the last hMG dose to the time of hCG ad-
ministration to 26 hours in the high E2 responders . 
Secondly , serum P levels were 3 times higher at the time of hCG 
injection and laparoscopy in the high E2 responders compared to 
norma l or low responders . Higher serum P values were seen at the 
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time of laparoscopy in follicles with dark granulosa cells and 
fragmented oocytes . It appears that excessive, premature eleva-
tion of P values (seen mainly in high responders) is detrimental 
to the follicle and oocyte . 
In further analyses o f their results with the second stimulation 
regime , Jones, Acosta , Andrews et al (1983) concluded that the 
best pregnancy rates were from the high responders . In 175 con-
secutive patients who underwent laparoscopy, 26 were high 
responders , 109 normal responders , and 40 low responders . The 
number of follicles per cycle were 5 . 5 , 4 . 26 and 4 . 1 for high , 
normal and . low responders, respectively . An average of 1 . 69 , 1 . 47 
and 1 . 05 preovulatory oocytes were obtained per cycle producing a 
~regnancy rate of 23% , 19% and 15% for the high , normal and low 
responders . 
~elatively high doses of hMG had also been used successfully for 
lVF (Laufer , deCherney , Haseltine et al, 1983) . The authors 
reported a mean of 19 +4 ampoules of hMG per cycle were used, 
~tarting from day 3 at 3 ampoules/day . However, in 55 laparo-
~copic oocyte recoveries, a mean of 4 . 3 follicles were aspirated, 
~nd 3 . 2 oocytes/patient was recovered . An average of 3 . 5 embryos 
were transferred , and 17% conceived . Inspite such high hMG doses, 
B% of the cases did not respond adequately . 
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There was a positive correlation between body weight, length of 
hMG stimulation, and oocyte fertilization rate (Halme, Hammond, 
Talbert et al, 1986). One hundred and four normally cycling women 
were treated with a fixed low-dose hMG regimen (2 amp/day) from 
day 3 till serum E2 was above 400 pg/ml or at least 2 follicles > 
14 mm in largest diameter were measured by ultrasonography. The 
response rate was found to be related to age, weight, and the 
ratios weight/height 2 and weight/height. The required dose of hMG 
was related to total body weight, but not to age or either of the 
weight/height ratios. In patients who require fewer than 5 days 
of hMG (rapid responders), a signifiacntly higher number of 
oocytes were harvested, compared with slow responders. However, 
fertilization rate was less for the rapid responders, and this 
resulted in a reduced embryo transfer rate. The pregnacy rates 
were 11% and 17% for the rapid and slow responders respectively 
(not significant). The authors suggested that patients undergoing 
IVF who weigh less than 55 kg may benefit from treatment with a 
lower dose of hMG to prolong the stimulation cycle. 
The use of purified FSH (Metrodin , Serono) in combination with 
hMG has been reported by Bernadus, Garcia, Jones et al (1984), 
Muasher, Garcia, Rosenwaks (1985) and Jones, Acosta, Garcia et al 
(1985a). Rosenwaks, Muasher and Acosta (1986) reported that 
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purifi e d FSH was use d in the stimula t i on of "poor " r es ponde r s ; of 
1 2 such pa tie nts t rea t ed , 8 we r e adequa t e l y stimulated , a nd 5 o f 
the m b e came pre gna nt . Howe v e r, after trying various combina t i ons 
of purified FSH with hMG and pure FSH alone in IVF, Jones (1986) 
r e porte d that protocols with a shifting ratio of FSH to LH gave 
slightly better r e sults than FSH alone . Moreover, protocols with 
r a tio of FSH to LH gre ater than one had a statistically better 
pregnancy rate. FSH administered without LH induces estroge n syn-
thesis similar to that induced by equal amounts of FSH and LH, 
and increased numbe rs of follicles and oocytes with apparently 
normal pregnancy potential (Channing, Liu, Jones et al, 1983) . 
The administration of FSH only is associated with somewhat higher 
estrogen values, prior to discontinuance of FSH stimulation , and 
slightly larger follicles than those seen with FSH/LH stimulation 
(Jones , Acosta , Garcia et al , 1985b) . These factors must be con-
sidered in monitoring "pure" FSH cycles. 
Another method of administrating gonadotropins for stimulation of 
multiple follicles for IVF is by pulsatile injections. Afnan, 
Hillier , Margara et al (1984) r e ported on a successful IVF at-
tempt resulting in a clinical pregnancy ; after clomiphene ad-
ministration from days 3 to 7 , 2 ampoules of hMG daily was ad-
ministered i . v . every 90 minutes on days 8 to 10 through a pump . 
There were 2 follicles on her left ovary and 4 on her right . 
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Seven oocyte s were collected and 6 fertilized. 
It is genera lly accepted that during a normal menstrual cycle 
ovulation blocks further maturation of additional follicles, 
either locally, centrally, or both. Themid-cycle progesterone 
rise is implicated in both mechanisms (Fritz and Speroff, 1982). 
With ovulation induction, especially with gonadotropins, multiple 
ovulation leading to multiple pregnancies is a common occurence. 
The probability of asynchronous ovulation during ovulation induc-
tion was suggested by the recovery of multiple ova at different 
stages of maturation in IVF programs. In fact, there was a recent 
case report of multiple ovulations in a gonadotropin-induced 
cycle occurring within an interval of 110 hours from the time of 
commencement of the mid-cycle surge triggering the first ovula-
tion to the time the last Graafian follicle was about to rupture 
(Navot, Margalioth, Laufer et al, 1984). One egg was recovered 
from a ruptured follicle, and it fertilized and cleaved to 4-
cell. 
4. Clomiphene with hMG 
There have been a few studies comparing clomiphene citrtate, 
clomiphene citrate augmented with hMG, clomiphene citrate fol-
lowed by hMG, and hMG alone. Vargyas, Morente, Shangold et al 
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(1984) compared 4 protocols: Group I consisted of clomiphene 150 
mg per day from days 3-7; group II received clompihene 150 mg/day 
from days 5-9 followed by 2 ampoules of hMG from 3-5 days until 
adequate follicular development; group III patients received 
clomiphene 150 mg/day from days 3-7 as well as 2 ampoules hMG on 
days 3, 5, 7 , 8 , 9, 10 and 11 of the cycle; and group IV received 
2 ampoules of hMG starting on day 3 and extending 6 to 8 days un-
til adequate follicular maturation had occurred . hCG 4000 iu was 
administered on the day ultrasound revealed at least one follicle 
>18 mrn diameter . 
The mean number of follicles per patient was 3 . 3 , 6 . 0 , 4 . 5 and 
4 . 3 for groups I, II , III and IV , respectively . These numbers 
were significantly higher for group I . The mean number of embryos 
transferred per patient was 2 . 2 , 3 .0, 2 . 4 , 1 . 5 for groups I , II , 
III and IV respectively . Pre-ovulatory E2 levels were lower in 
groups I and IV . Fertilization rates were highest in groups II 
and III , and slightly lower in groups I and IV . Only 3% of group 
II patients had a spontaneous LH surge prior to hCG as opposed to 
33% of group IV patients . The best overall results were observed 
in group II (clomiphene followed by hMG) followed by group IV 
( hMG alone ), though the numbers were small . 
Quigley, Schmidt, Beauchamp et al ( 1984) reported a randomized 
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study which compared clomiphene 50 mg/day from days 5-9 of the 
cycle (group I), with clomiphene-hMG combination where the 
clomiphene was given as before and 2 ampoules of hMG on days 6, 8 
and 10 (group II). The mean number of follicles per patient were 
significantly higher in group II (5.1 vs 3.7). There was a higher 
number of follicles 10-14 mm in size seen in group II; however, 
no difference was noted in number of follicles from 15 mm 
diameter . Oocytes (mature and immature), fertilization and 
cleavage rates were similar in both groups. More embryos were 
transferred in group II (2.5 vs 2.0), but this was not sig-
nificant. There were 2 clinical pregnancies in 12 transfers in 
group I, and 2 pregancies in 13 transfers in group II. The 
authors believed that clomiphene plus hMG (in combination or in 
sequence) appears better than clomiphene citrate alone . 
In a very large comparative series, Trounson and Wood (1984) 
reported on the stimulation with clomiphene in 418 patients, hMG 
alone in 21 patients, and clomiphene-hMG combination in 364 
patients, together with 71 unstimulated patients. There were 160 
embryo replacements in the clomiphene group, 5 in the hMG group, 
and 224 in the clomiphene-hMG group; the pregnancy rates were 
21.25%, 60.0%, and 19.2% respectively. However, there was no data 
on the average number of follicles, eggs, embryos and E2 response 
in the 3 groups. 
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In another recent report on comparison of various stimulation 
r e gimes (Diamond, Hill, Webster, et al, 1986), hMG was given at 2 
or 3 ampoules/day from day 3 for 2 days, then 2 ampoules/day un-
til maturity (group I- 181 patients); clomiphene was given at 
150 mg/day from days 3-7 (group II - 42 patients); hMG for the 
clomiphene-hMG combination was 2 ampoules/day from day 6 or 7 
(group III - 81 patients). The ovulating dose of hCG was 4000 iu. 
Patients undergoing laparoscopic recovery were not significantly 
different in the 3 groups (69 %, 71%, and 74% respectively), nor 
were the rates of oocyte recovery (94 %, 100%, and 100%). However, 
the percentage of women achieving fertilization (77%, 83% and 
93%) and embryo transfer (73%, 83%, and 90%) were significantly 
greater in group III (clomiphene-hMG combination). However, there 
was no increase in pregnancy rates in the combined regime. 
The amount of clomiphene given before the hMG stimulation did not 
affect the follicle numbers or fertilization rates (Bayly, 
McBain, Clarke et al, 1985). 283 patients had clomiphene 100 
mg/day, with hMG from the fifth day of clomiphene until maturity; 
85 patients had similar stimulation but with reduced clomiphene 
at 50 mg/day. There was no difference in number of hMG ampoules 
(12 ampoules each), days of hMG (4.3 and 4.4 respectively), and 
cycle day of oocyte recovery (day 14.3 for both). Peak E2 values 
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were 1,900 pg/ml for both, with 4.4 and 4.5 eggs per recovery 
respectively, 2.1 and 2.2 embryos per recovery respectively , and 
pregnancy rates at 17.7% and 14.1% per recovery respectively. The 
only significant difference was the lower incidence of spon-
taneous LH surges in the group with higher clomiphene dose (20% 
Versus 34% respectively). 
~hen the hMG is given in a combined clomiphene-hMG protocol it 
has different effect on the outcome. In a unique cross-over trial 
involving the two main IVF centres in Melbourne, Rogers, Molloy , 
Healy et al (1986) reported higher pregnancy rates with the 
Monash protocol. The Monash protocol utilized the calculation of 
the predicted day of the spontaneous LH surge based on 6 previous 
cycles, and clomiphene was given at 100 mg/day starting 10 days 
before the predicted surge; hMG was given at 2 ampoules/day 
starting 9 days before the predicted LH surge, and continued till 
the E2 response was between 500 and 1000 pg/ml and showed a 
steady rise. The other centre, the Royal Women's Hospital (RWH), 
started clomiphene (100 mg/day) between days 3 and 5 depending on 
the cycle length; hMG at 3 ampoules/day was started when the E2 
showed a positive rise (of above 1.5 times previous mean) and 
continued for 4 days. There was no difference in amount of hMG 
given. The average number of oocytes per patient were 3.4 for the 
Monash patients on RWH protocol (Monash control 3.8), and 7.0 for 
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the RWH patients on the Monash protocol (RWH control 5.2). Preg-
nancy rates were 8 % for Monash patients on RWH protocol (Monash 
control 15%), and 30% for RWH patients on Monash protocol (RWH 
control 21%). It does seem that the Monash protocol yielded bet-
ter results, though that was not statistically signifcant. 
It has been reported that use of clomiphene with hMG for IVF 
resulted in high LH levels in peripheral blood (Jeffcoate, 1985). 
Such high LH levels may cause premature activation of the egg 
which is capable of fertilization and cleavage, but fails to 
implant; excess LH may cause down-regulation of LH receptors with 
abnormalities in the follicular response to the LH surge and 
defects in luteal function. It may also cause premature 
luteinization of the granulosa cells with resulting P production. 
Such abnormal P production may cause asynchrony between embryo 
stage and endometrium ; it may also increase PRL production with 
consequent disruption in ovulatory response. 
Okamoto, Healy, Howlett et al (1986) reported the 5th and 95th 
percentile envelope of plasma E2 concentrations from 102 consecu-
tive IVF conceptions after stimulation with clomiphene-hMG. The 
mean E2 levels on the day before the calculated mid-point 
(anticipated LH surge) at the 50th, 5th and 95th percentile were 
1656 pg/ml, 740 pg/ml and 3638 pg/ml respectively. The plasma E2 
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range reported defined objectively the diagnosis of ovarian hy-
perstimulation and inadequate stimulation in an IVF program. A 
n ew approach in the monitoring of follicular stimulation is the 
use of salivary E2 ; this may obviate multiple venepunctures for 
patients (Belkien, Bordt, Moller et al, 1985). 
5. Use of GnRH or their analogues for IVF 
In order to lower the LH levels associated with clomiphene-hMG 
cycles, and to increase the number of follicles from the same 
cohort, attempts have been made on suppressing endogenous 
gonadotropins with GnRH analogues, usually Busserelin. There were 
a few such reports presented in the 4th World Congress on IVF 
held in Melbourne, November 1985 (Bordt, Belkien, Hanker et al, 
1986; Porter, Smith, Craft et al, 1986; Pring, Setchell, Quinn et 
al, 1986; Sharma, Riddle, Williams et al, 1986). There were large 
numbers of oocytes collected after stimulation with either hMG or 
Purified FSH, and because they were of different maturity they 
were obviously from different cohorts. Until the full papers are 
Published it is rather difficult to comment on their use. 
6. ~ of other agents for control of stimulation in IVF 
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In an attempt to synchronise ovulation, and therefore simplify 
and i mprove on logistic planning for an IVF program, Frydman, 
Forman , Rainhorn et al (1986) reported on the use of a triphasic 
estrogen-progestin contraceptive pill or a progestin 
(nore thisterone) on the cycle before the planned IVF cycle. Fol-
lowing this "pre-treatment" (day 0 was the day the pre-treatment 
ended) the patient was stimulated with clomiphene 100 mg/day from 
days 2 through 6, and hMG 2 ampoules/day on days 2, 4, 6, 8 and 
10. hCG (5000 iu) was administered on day 11 and egg retrieval 
was done on day 13 (35 hours after the hCG). No hormonal or 
ultrasonic monitoring was done. In 35 cycles compared with 34 
control cycles, there were 3.9 and 4.8 follicles at egg retrieval 
respectively, 2.7 and 3.2 oocytes recovered/retrieval respec-
tively, 2.0 and 2.4 embryos/retrieval respectively, and 8 and 4 
clinical pregnancies respectively. Because there was no improved 
pregnancy rate in the control group, the authors suggested that 
the usual monitoring methods are suboptimal, being unable to 
define the subgroup of patients to proceed to aspiration who were 
more likely to develop a clinical pregnancy than an unmonitored 
population. Also, they were concerned with identifying the treat-
ment schedule associated with the highest incidence of high 
responders. However, they felt that their preliminary results 
justified adopting a fixed schedule ovulation regimen for their 
patients. 
94 
Another approach is the use of pulsatile GnRH to stimulate fol-
liculogenesis. Multiple follicles can be induced with pulsatile 
GnRH therapy (Bogchelam, Lappohn and Janssens, 1982; Liu, Durfee, 
Muse et al, 1983). Hence it is possible to use this approach for 
IVF stimulation. This has been reported by Kerin, Broom, McEvoy 
et al (1984) who used subcutaneous pulsatile GnRH for stimulation 
but the response was unsatisfactory. 
Patients with incipient ovarian failure, with elevated FSH in the 
early follicular phase and normal LH, characteristically do not 
respond to hMG treatment, or they may have a rapid response with 
a premature LH surge (Jones, Muasher, Rosenwaks, et al, 1986). To 
overcome these problems, the authors administered intravenous 
pulsatile GnRH 5-10 ug/90-120 min to 8 such patients. Two 
patients failed to respond with follicular maturation. Another 4 
could have had unrecognised LH surge; 3 had no oocytes aspirated 
from apparently postmature follicles or had postmature oocytes, 
and 1 had treatment cancelled due to ovulation. In the remaining 
2 patients, one oocyte was fertilized and transferred, and one 
pregnancy resulted. 
7. Spontaneous LH surge 
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In a clomiphene-hMG study which compared 8 patients who had spon-
taneous LH surge with 7 patients without spontaneous LH surge 
(Nader, Berkowitz, Maklad, Wolf et al, 1986), there was a sig-
nificantly higher E2 per follicle >15 mm on the morning of the 
hCG administration or LH surge in the LH surge group. However, 
non-surge patients had a greater number of follicles ~15 mm. The 
authors believe that greater quantities of nonsteroidal hormones, 
eg inhibin, produced by a greater number of preovulatory fol-
licles in nonsurge patients, may block the pituitary response to 
hypothalamic GnRH in the presence of high and rising E2 , thus 
preventing the spontaneous LH surge. 
In a later report, the authors looked at the E2 pattern in the 
patients with spontaneous LH surge (Nader, Berkowitz, Ochs et al, 
1986). They distinguished 2 patterns -a "leap" pattern, where 
the rate of E2 rise increased progressively until peak E2 was 
reached, or when the change in E2 between the peak and the pre-
vious day's value exceeded 300 pg/ml; a "plateau" pattern, where 
the rate of rise declined as the LH surge approached or where the 
change in E2 between the peak and the previous day's value was < 
100 pg/ml. Of the 16 cycles, 9 had "leap" patterns and 7 had 
"plateau " patterns. There was no difference between the groups in 
the peak E2 attained, and the number of follicles >12 mm on the 
day of peak E2 • However, when the number of follicles >12 mm 
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ations of follicles . An inadequate luteal phase results because 
there is a direct relationship between the number of small, un-
ripe follicles at the time of follicular aspiration , and the ex-
istence of a "relative" deficiency of P which can be detected in 
the luteal phase (Lehman, Diedrich, van der Ven et al, 1984). 
Excessive exogenous gonadotrophins may also result in hyper-
trophied aggregates of smooth endoplasmic reticulum in the 
cytoplasm of the egg (Sathananthan, Ng, Ratnam et al, 1986). Such 
morphological change is indicative of excessive steroidal output; 
while this association is clear in granulosa cells, its sig-
nificance in the egg is still uncertain. 
Finally, there is a possibility that there may be an increase in 
chromosoma~ abnormalities as a result of excessive stimulation. 
The proportion of human oocytes with chromosomal abnormalities is 
not yet known. However, recently Wramsby, Fredga and Liedholm 
(1987) reported that infertile women undergoing clomiphene 
stimulation have a high proportion of oocytes (nearly 50%) with 
an abnormal karyotype. It may be that the more abnormal forms of 
oocytes that would normally undergo atresia were "rescued" by 
ovulatory drugs. If so, then overstimulation with gonadotropins 
~ould result in more oocytes, and hence more abnormal oocytes. 
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CHAPTER 3: 
MATERIALS AND METHODOLOGY 
PATIENTS 
When the IVF program was in progress at the Kandang Kerbau Hospi-
tal, there was no GIFT program available. Hence the indications 
for patients for inclusion into the IVF program were: 
1. tubal blockage or disease in the female 
2. male infertility: oligospermia or oligoasthenospermia 
3. idiopathic subfertility 
(i) subfertility of more than 5 years in female 
patients below 30 years of age; 
(ii) subfertility of between 2 and 5 years in female 
patients above 30 years of age. 
4. miscellanous (immunologic infertility and endometriosis) 
In phase I (July 1982 to May 1983), the patients were either 
unstimulated or were superovulated with clomiphene citrate 
(Clomid , Merrell). Twenty-two patients were involved in 33 
patient cycles (Ng, Ratnam, Law et al, 1984). Their ages ranged 
from 25 to 39, with a mean of 31.9 years. Thirteen patients had 
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tubal obstruction, 4 had oligospermia, 4 had idiopathic subfer-
tility , and 1 had endometriosis (table 3.1 ). 
Phase II (September 1983 to September 1985) included 100 patients 
in 105 cycles, with 100 laparoscopies (table 3.1 ). Their ages 
ranged from 29 to 40, with a mean of 32.9 years. The majority of 
patients had tubal obstruction (48.0%), while 22.0% had a com-
bination of indications (table 3.1 ). 
STIMULATION REGIME: PHASE I 
Superovulated patients were orally administered 50 mg of 
clomiphene citrate (Clomid, Merrell) three times a day for 5 days 
commencing on day 2 (Ng, Ratnam, Law et al, 1984). Plasma E2 
levels were monitored from day 8 onwards. Ultrasound scans were 
initially performed on day 9, but later carried out daily from 
day 8 onwards (see chapter 9). When the dominant follicle had at 
least a diameter of 1.5 em or more, the patient was admitted. 
Three-hourly urine samples were assayed for LH. In the absence of 
an endogenous LH surge, 5000 iu of hCG (Pregnyl, Organon) was 
given intramuscularly when the dominant follicle had an obvious 
cumulus oophorus or a diameter of 2.0 em or more. 
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Daily ve nous samples we re obtained from the antecubital vein be-
tween 8 a nd 9 am . Unconjugated plasma E2-17B was measure d by 
radioimmunoa ssa y, using rabbit antiserum to 6,7-3H- 17B estradiol 
with a tota l incubation time of about 2 hours . The 3-hourly urine 
samples we re collected throughout the 24 hours , with fluid intake 
restricte d to 1 . 5 litres pe r day . LH was measured by a haemag-
glutina tion inhibition kit method , Higonavis ( Mochida Phar-
maceuticals, Tokyo), twice daily . The details of this method are 
given in chapter 8 . 
STIMULATION REGIME : PHASE II 
Fifty mg of clomiphene was orally administered twice a day from 
day 2 for 5 days . On day 6 , hMG ( Pergonal , Serono ) was injected . 
In regime I, one ampoule ( 75 i . u . of FSH and 75 i . u . of LH ) was 
given daily from day 6 to day 8 , while in regime II , 2 ampoules 
( 150 i . u . of FSH and 150 i . u . of LH) were injected each day for 
the same duration (Ng, Ratnam, Law et al , 1985a ). From day 9 , the 
hMG dosage was dependent on the plasma E2 levels and taken daily 
at 8 . 30 am (see chapter 6) . If the E2 value was less than 150% of 
the pre vious day's level, 1 ampoule of hMG was added to the pre-
vious day ' s dose. If the E2 value was more than 200% of the pre-
vious day ' s l e vel, 1 ampoule was deducted from the previous day's 
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dose. If the level was between 150 to 200%, the dose was main-
tained. All hMG injections were given at 4.00 pm. An ultrasound 
scan was carried out on day 9 to determine the number of the fol-
licles. No repeat scan was done unless necessary as it interfered 
with the urinary LH monitoring. Moreover, recruitment of fol-
licles after day 9 has been reported to be rare (Blankenstein, 
Saadon, Mashiah et al, 1984). The patient was admitted when the 
E2 level reached 400 pg/ml/follicle. Urine was then collected 2 
to 4 hourly, and LH values determined with Hi-Gonavis (Mochida, 
Tokyo) twice daily by the modified method of Edwards, Anderson, 
Pickering et al (1982). In the absence of the LH surge, 10,000 
i.u. of hCG was given when the plasma E2 level reached either 500 
or 700 pg/ml/ml; a "coasting" period (period during which hMG was 
not given,ie the interval between the last hMG dose to the hCG 
injection, in hours) of at least 32 hours was allowed (Brown, 
1978). 
~ RECOVERY 
Laparoscopy was done 24-26 hours after the onset of the LH surge, 
or 34-36 hours after the hCG injection. The technique of oocyte 
aspiration was that described by Renou, Trounson, Wood et al 
(1981 ), using a ·single lumen needle (Monash oocyte aspiration 
102 
needle, Rocket of London) . 
In phase I, there were 22 laparoscopic egg recoveries (table 
3.1 ). The majority of cases that did not reach laparoscopy had 
abnormal follicular growth (see chapter 5) . Of the 22 cases that 
had laparoscopic egg recovery, 14 had spontaneous LH surge; 12 
oocytes were recovered from 11 patients (table 3.2). 
In phase II, there were 100 patients in 105 cycles with 100 
laparoscopies and 238 eggs were recovered from 85 patients (table 
3. 2 ) • 
FERTILIZATION AND GROWTH IN VITRO 
After the oocyte was collected, it was matured for 6 hours in 
Whittingham 's T6 medium before insemination (Ng, Ratnam, Law et 
al , 1985b). The semen was collected about an hour before insemi-
nation, and w'ashed twice with T6 and centrifuged at 1800 rpm 
before layering for half an hour at 37°C. Spermatozoal concentra-
tions of 0.25 to 0.50 million/ml were used. The egg was examined 
16-18 hours later for evidence of fertilization, viz. two 
Pronuclei and two or more polar bodies. Twenty-four hours later, 
the zygote reached the 2-4 cell stage. The medium for fertiliza-
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tion and growth was T6 supplemented with heat inactivated 
homologous human serum at 10% and 15% (v:v) respectively. 
EMBRYO REPLACEMENT 
Replacement of the pre-implantation embryo was between the 2- to 
8-cell stage. The technique was as described by Leeton, Trounson, 
Jessup et al (1982). Briefly, the embryos were drawn into an in-
ternal catheter together with 30 - 50 ul of transfer medium using 
a 1 ml tuberculin syringe. An external sleeve was then introduced 
gently without anaesthesia through the cervical canal just past 
the internal os. The internal catheter was then pushed through 
into the uterine cavity through the external sleeve such that it 
protuded 2 - 4 em beyond the tip of the sleeve. The embryos were 
then displaced into the uterine cavity by depressing the plunger 
of the attached syringe. 
LUTEAL PHASE SUPPORT 
In phase I, the luteal phase was supported with 500 mg of 170H-
progesterone caproate (Depo Proluton, Schering AG) injected twice 
a week. 
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In phase II, the luteal phase was supported by either proges-
terone or a placebo (vit B Co) in a randomised trial (see chapter 
10 for details). Plasma was collected from the patients once 
every 2 days from the day of oocyte recovery and assayed for E2 , 
P and beta-subunit of hCG. Plasma P and hCG were assayed 
retrospectively. 
PREGNANCIES 
In phase I there was one pregnancy in 8 replacements (12.5%). In 
phase II there were 1l pregnancies in 59 replacements (18.6 %) ; 2 
were biochemical pregnancies while 4 were abortions and 5 were 
singleton pregnancies that delivered normal children at term. 
When the number of embryos replaced were considered (see table 
3.3), the rates improved with multiple embryo replacements, up to 
3 embryos . 
~ADIOIMMUNOASSAY (RIA) OF ESTRADIOL-17B AND PROGESTERONE 
~stradiol-17B (E 2 ) and progesterone , were measured by specific RIA 
wth reagents supplied by WHO {WHO Method Manual, 6th edition , 
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1982). Specific antisera toP and E2 were raised in rabbits by 
coupling 3-carboxymethyl oxime-bovine serum albumin with the 
respective steroid. For the E2 assays, 500 ul of plasma was ex-
tracted with freshly distilled diethylether. The organic ether 
phase was pipetted and dried by heating in a water bath at 45°C. 
The extracts were dissolved in 0.5 ml of phosphate buffered 
saline at pH 7.2 containing 0.1% gelatin (assay buffer). Stand-
ards made up in assay buffer wih pure E2 at a range between 7.8 
to 250 pg/ml were analysed with each set of samples assayed. 
Duplicate aliguots (500 ul) were placed in tubes for RIA. For the 
zero blank (B0 ) representing maximum binding of antibody and 
tracer, 500 ul of assay buffer was added. Tubes for nonspecific 
binding and total counts were added with 600 ul buffer. 100 ul 
aliguots of anti-E 2 was added to all tubes except total count and 
non-specific binding tubes and incubated for 1 /2 hour at room 
temperature. This was followed by the addition of 100 ul of 3 H-E2 
to all tubes and incubation for 1 hour at 4°C. 200 ul of ice-cold 
dextran-coated charcoal (0.625 g charcoal Norit A with 0.625 g 
dextran in 100 ml assay buffer) was then added and vortex mixed. 
~hereafter all tubes were reincubated for 15 min at 4°C. At the 
~nd of the incubation period, the tubes were centrifuged at 2300g 
tor 5 min at 4°C. The supernatant was decanted into a scintilla-
tion vial containing 10 ml of toluene-based scintillation fluid 
with Triton X-10. Radioactivity was estimated in a Hewlett-
1 06 
Packard liquid scintillation spectrometer (Packard Tri-Carb 300) 
for 5 min having 65% efficiency for tritum. 
P assays were performed with specific antisera raised in rabbits 
by the same method described above except that the incubation 
period after addition of the radiolabelled tracer, antiserum and 
standards (range between 12 and 200 ng/ml) or samples was 24 
hours at 4°C. The intra- and inter- assay coefficient of varia-
tion for E2 was 7.3% and 10.4% respectively while that for P was 
6.7% and 9.6% respectively. 
107 
TABLE 3.1: INDICATIONS FOR INCLUDING PATIENTS IN IVF PROGRAM 
Indications Phase I Phase II 
(July 82-May 83) (Sept 83-Sept 85) 
Tubal obstruction 1 3 48 
Tubal disease 5 
Sperm problems 4 9 
Endometriosis 1 6 
Idiopathic 4 8 
Immunological 2 
Combination 22 
--------
---------
Total 22 1 00 
1 08 
~ABLE 3.2: OUTCOME OF LAPAROSCOPIC EGG RECOVERIES 
Phase I Phase II 
------- --------
Laparoscopies 22 100 
Successful recoveries 11 85 
Oocytes recovered 12 238 
Fert. & cleavage 9 11 6 
Embryo replacements 8 59 
Pregnancies 1 1 
1 09 
TABLE 3.3: RELATIONSHIP OF NUMBER OF EMBRYOS REPLACED TO PREG-
NANCY RATES 
Number 
embryos 
replaced 
---
2 
3 
4 
5 
---
Total 
Phase I 
-----------------
Cases 
------
7 
1 
------
8 
Pregn 
1 (14.3%) 
1 (12.5%) 
11 0 
Cases 
1 5 
25 
1 4 
3 
2 
59 
Phase II 
Pregn 
2 (13.3%) ' 
5 (20.0 %) 
4 (28.6 %) 
11 (18.6%) 
CflAPTER 4 : 
S!NGAPORE'S FIRST TEST-TUBE BABY 
The f 
ourth patient in the IVF program was a 25 year old Chinese 
female with 4 years of primary subfertility. In her August cycle, 
she 
Was on clomiphene citrate 50mg tds from day 2 to day 6. By 
day 12 she had a single follicle on her right ovary measuring 1.4 
* 1
•
6 
* 1.6 em and was admitted. On day 15 the follicle was 1.9 * 
2.s * 1 
. 8 em, with a cumulus oophorus measuring 0.7 em. As 3 
hourl Y urine for LH showed no spontaneous surge, hCG 5000 i.u. 
was 
given and the laparoscopy was performed 30 hours later. A 
Single follJ.' cle h . 2 5 . d. on the rig t ovary, measur1.ng • em J.n J.ameter, 
was 
aspirated: A single preovulatory oocyte was obtained and cul-
tured 1.· n b f · · t · S T6 medium for 6 hours e ore 1.nsem1.na 1.on. eventeen 
hours 1 4 11 ater 2 pronuclei were noted. The -ce preimplantation 
embr 
Yo was transfered 46.5 hours after insemination. On the 37th 
day 
after laparoscopy, a gestational sac was seen on ultra-sound. 
'l'he 
Patient delivered on 19th May 1983 after induction. 
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I NTRODUCTION 
The e mbryo culture laboratory was started in Singapore in Decem-
ber 1981 after gaining experiences from Monash University, Mel-
bourne, over a period of 4 weeks in June 1981. The initial 6 
months we re occupied with murine experiments. Only after it was 
possible to obtain cleavage in 80 - 100% of murine eggs fertil-
ized in vitro to 2-cell stages that the IVF program on the human 
commenced (July 1982). 
The first patient was a 29 year old Chinese who had bilateral 
tubal damage. She had 3 follicles after clomiphene stimulation. 
Laparoscopic recovery of eggs was unsuccessful, possibly because 
two Fa lcon test-tubes had to be rotated throughout the operation. 
The second patient was a case of irreversible tubal occlusion, 
and had only one follicle following clomiphene. Her laparoscopy 
was timed 25 hours from the onset of the spontaneous LH surge; 
howeve r, the laparoscopy was too late as ovulation had occurred 
spontaneously. The third patient was a 30 year old Indian who had 
a previous salpingectomy for an ectopic pregnancy, and the 
r e maining tube was hypoplastic. An egg was recovered from a 
single follicle following clomiphene, and after fertilization 
deve lope d to 8-ce lls in 59 hours. However, the embryo transfer 
was difficult and no pregnancy ensued. 
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THE PATIENT 
The fourth patient resulted in our first IVF pregnancy. She was a 
25 year old Chinese who had 4 years of primary subfertility due 
to bilateral cornual obstruction of her Fallopian tubes . Her last 
menstrual period was on 28 August 1982 . Clomiphene was taken at 
50 mg t.d.s . from day 2 for 5 days. On her 10th day, ultrasound 
examination revealed a follicle 1.1 * 1 . 1 * 1 . 1 em on her right 
ovary. This grew to 1.4 * 1 . 6 * 1.6 em on day 12 when she was 
admitted, and to 1 . 9 * 2 . 5 * 1 . 8 em on day 15 with a cumulus 
oophorus measuring 0.7 em . Her serum E2 measured 232 pg/ml on day 
10, and increased to 1085 pg/ml on day 14 (see table 4.1 ). Three-
hourly urine measurements for LH by Higonavis from day 12 showed 
no spontaneous surge . Intra-muscular hCG 5000 i.u. was given on 
day 15 and the laparoscopic recovery timed 30 hours later . A 
single pre-ovulatory follicle measuring 2 . 5 em in diameter was 
seen and aspirated and a preovulatory egg was obtained . 
~ERTILIZATION AND GROWTH 
~he egg was matured for a further 6 hours in 0 . 5ml of T6 medium 
11 3 
with 10 % heat inactivated human serum and 0.5ml of follicular 
fluid before insemination. The semen was collected 2 hours before 
insemination, washed with medium, centrifuged at 500 rpm for 10 
minutes and layered with O.Sml medium. After 30 minutes the 
supernatant was collected. Half a million treated spermatozoa in 
27 ul were then introduced into the Falcon tube with the ovum. 
After 17.5 hours, 2 pronuclei were seen. Growth times were within 
those reported by Edwards et al, 1981 (see table 4.2). 
EMBRYO REPLACEMENT 
The 4-cell embryo was transferred using the method described by 
Leeton, Trounson, Jessup et al, 1982. The catheter used was a 
Monash Embryo Transfer Set I William A. Cook Australia Pty 
Ltd.) The transfer was carried out with the patient in lithotomy 
position without any anaesthesia and any difficulty. The 
volume of medium transferred with the embryo was 20 ul. 
POST REPLACEMENT REGIME 
The patient was placed on complete rest in bed in the supine 
position for 24 hours. Depo Proluton (17-0H progesterone 
1 1 4 
caproate, Schering AG) was administered at a dosage of 250 mg on 
POD1 (1st day after laparoscopy), 500 mg on POD2, POD3, PODS 
and subsequently twice a week from POD12. Her B-hCG showed a 
rise by the 11th POD (9th day after ER) (see table 4.3). Ultra-
sound examination showed a gestational sac on the 23rd POD, 
measuring 5 * 5 * 4 mm. 
Her pregnancy progressed satisfactorily. Ultra-sound biparietal 
diameters were within acceptable limits (see figure 1 ), while 24 
hour urinary estriols were satisfactory. Antenatal car-
diotocographs from the 32 week of gestation were reactive. Labour 
was surgically induced on 19th May 1983, at the beginning of the 
38th week of gestation and was delivered by forceps 7.5 hours 
later. The healthy male infant, weighing 2535 gm, was 
without any obvious congenital defects. 
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TABLE 4 .1: FOLLICULAR VOLUME AND SERUM ESTRADIOL LEVELS IN FIRST 
PREGNANCY 
Day of cycle 
1 0 
11 
1 2 
1 3 
1 4 
1 5 
1 6 
Serum estradiol 
(pg/ml) 
232 
408 
396 
795 
1085 
11 52 
1073 
11 6 
Follicular volume 
(cc) 
0.70 
1 • 33 
1 • 88 
2.27 
2.67 
4.48 
2.26 
TABLE 4.2: IN VITRO GROWTH OF EMBRYO IN FIRST PREGNANCY 
Stage Time from insemination 
2 pronuclei 1 7. 5 
3 blastomeres 34.75 
4 blastomeres 46.0 
(hours) 
* Ref: Edwards, Purdy, Steptoe et al, 1981. 
11 7 
Expected time * 
(hours) 
49.0 + 1.3 
TABLE 4.3: ESTRADIOL, PROGESTERONE AND HUMAN CHORIONIC 
GONADOTROPIN LEVELS FOLLOWING LAPAROSCOPY 
Days after Estradiol Progesterone Human chorionic 
laparoscopy (pg/ml) (ng/ml) gonadotrophin (miu/ml) 
----------- ---------- ----- ----- -------------------
5 387 23 . 6 10 . 3 
8 281 21 • 0 4 . 9 
11 416 28 . 9 >500 
1 4 804 36 . 9 >500 
1 7 518 30 . 8 >500 
20 935 41 • 2 >500 
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CHAPTER 5: 
FOLLICULAR PHASE IN UNSTIMULATED AND CLOMIPHENE-INDUCED CYCLES 
SYNOPSIS 
Patients were initially either unstimulated or stimulated with 
clomiphene citrate 50 mg tds for 5 days from day 2 . Previous 
studies of E2 response assume that eggs were present in the fol-
licles monitored . Only patients in whom at least one egg was 
recovered at laparoscopy were considered in this analysis . Six 
patients had clomiphene and 4 patients were unstimulated. One to 
3 follicles were present in the clomiphene-treated group , while 
all the unstimulated patients had 1 follicle each . Four of the 
clomiphene-induced patients required hCG administration , as op-
posed to 1 patient in the unstimulated group while the rest had 
spontaneous LH surge . The mean plasma E2 level varied from 195 
pg/ml/follicle 7 days before laparoscopy to 633 pg/ml/follicle on 
the day of the laparoscopy in the clomiphene-treated patients, 
and from 87 pg/ml/follicle 7 days before laparoscopy to 473 
pg/ml/follicle on the day of the laparoscopy in the unstimulated 
group . In 5 of the 10 patients, the E2 levels fell on the day of 
laparoscopy, . with the maximal values on the day prior to the 
. 
11 9 
r e covery . Only 2 o f the 6 clomiphene -trea t e d patients showe d a 
continue d rise . 
I NTRODUCTION 
Initial attempts were with unstimulated cycles in orde r to mimic 
the natural state. hMG was used subsequently in an attempt to im-
prove control of the cycles but was unsuccessful (Steptoe and Ed-
wards, 1979). This was later attributed to the use of a hMG 
r e gime designe d for anovulatory cycles (Edwards, 1983). The 
first two babie s delivered after IVF and ER were from unstimu-
lated cycles (Edwards, Steptoe and Purdy, 1980; Lopata, 
Johnston, Hoult et al, 1980). 
In 1981 Trounson, Leeton, Wood et al reported the successful use 
of clomiphene citrate in stimulating multiple follicular growth 
for IVF and ER, although its use had been advocated by Lopata, 
Brown, Leeton et al in 1978. This has led to its widespread use 
by many IVF and ER centres. More recently, hMG has been used 
successfully for IVF & ER (Jones, Jones, Andrews et al, 1982; 
Wortham, Vee ck, Witmyer et al, 1983) and this drug is now 
routinely used. 
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Phase I involved clomiphene citrate-induced and unstimulated 
cycles. The purpose of this chapter is to compare the E2 
response in these two regimes. 
MATERIALS 
The data presented were confined to subjects where at least 
one egg was recovered at laparoscopy. This was to exclude the 
possibility of abnormal follicular development and "empty" fol-
licles (Coulam, Bustillo and Schulman, 1986). This is in con-
trast with most clinical studies where ovulation is supposed, but 
not definitely proven, to have occurred. 
ln phase I, there were 22 patients involved in 33 patient cycles. 
~here were 22 laparoscopic egg recoveries and the majority of 
~ases that did not reach laparoscopy had abnormal follicular 
~rowth (table 5.1 ). Twelve eggs were recovered from 11 patients. 
Jf these 11 patients, one received hMG and this patient was ex-
~luded. Thus, for this analysis, there were 10 patients (6 
~lomiphene-induced and 4 unstimulated), ranging in age from 25 to 
~9 (mean 31.9 years). Nine patients had tubal obstruction, and 
)ne patient had idiopathic subfertility. 
1 21 
The treatment regime, egg collection, in vitro fertilization and 
growth, and embryo replacement were as described in Chapter 3 in 
the Materials and Methodology section. 
RESULTS 
The daily plasma E2 levels are given in table 5.2. Only 1 patient 
in the clomiphene-induced cycles had 1 follicle seen on laparos-
copy, whilst all patients in the unstimulated cycles had 1 fol-
licle each . Four of 6 patients in the clomiphene-induced cycles 
needed hCG injection, as opposed to 1 out of 4 in the unstimu-
lated cycles. The plasma E2 levels per follicle in the 
clomiphene-induced group are given in table 5.3. The range varied 
from 358 to 1255 pg/ml. The mean levels per follicle are given in 
table 5.4 and these were higher in the clomiphene-induced cycles. 
DISCUSSION 
Edwards, Steptoe and Purdy (1980) suggested that ovarian stimula-
tion with hMG may disturb the menstrual cycle, inducing a shorter 
luteal phase and a disorganised 
~ith establishing a pregnancy. 
endometrium, both incompatible 
It was subsequently shown 
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(Trounson, Leeton, Wood et al, 1981; Johnston, Lopata, Speirs et 
al, 1981) that cycles induced by clomiphene citrate and hMG for 
IVF & ER were compatible with pregnancies. Stimulated cycles 
resulted in more preovulatory follicles, more eggs at laparos-
copy, and higher pregnancy rates (Trounson and Conti, 1982). 
In unstimulated cycles in normal Chinese women, the peak level of 
total oestrogen was 508.8 pg/ml (Salmon, Chew and Ratnam, 1976). 
Saxena, Dusitsin and Vichai (1974) showed that the hormone 
profiles for estrogen, LH and P were similar in both Caucasian 
and Thai women. In our group of unstimulated cycles, a mean peak 
value of plasma E2 of 473 pg/ml was observed on the day of 
oocyte recovery. This is compatible with the level of E2 (500 
pg/ml) associated with successful IVF & ER cycles (Trounson, 
1982). 
In clomiphene-induced cycles, the mean E2 levels observed per 
follicle were much higher with values of 700 pg/ml on the day 
prior to and 633 pg/ml on the day of the laparoscopy. It is pos-
sible that clomiphene induced the growth of several follicles of 
which only a few ovulate and that the remainder do not continue 
to the preovulatory stage, but contribute to steroidogenesis. It 
was also observed by Smith, Picker, Sinosich et al (1980) that 
the mean plasma E2 levels in clomiphene-induced cycles were sig-
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nificantly higher than natural cycles, even when only one fol-
licle was present . 
In general, a rising trend in the E2 levels was observed with 
follicle maturation. The large standard deviations noted in this 
study were partly due to the small sample sizes. On the day of 
egg recovery, the range of plasma E2 per follicle vari ed from 
358 to 1255 pg/ml in clomiphene-induced cycles, and from 390 to 
629 pg/ml in unstimulated cyles. Absolute E2 levels are there-
fore poor indicators of follicular maturity. Rising trends were 
more reliable indicators of continued follicular development. 
Such a trend may lead to an endogenous LH surge before hCG could 
be administered; hence an accurate formula to predict when the LH 
surge could occur would be useful clinically (see chapter 9). In 
fact stimulated regimes should aim at a high proportion of 
spontaneous LH surges; this would be an index of satisfac-
tory endocrinological control in spite of an increase in the 
number of follicles . 
In 5 of the 10 patients, the E2 levels fell on the day of 
laparoscopy, the maximal values having occurred one day prior to 
the recovery. For an IVF program, this pattern is less satisfac-
tory than if the E2 levels had continued to rise after spon-
taneous LH surge or after injection of hCG . Pregnancy rates 
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were better in those in whom E2 levels continue to rise (Jones, 
Acosta, Andrews et al , 1983). It is of interest to note that of 
the 6 clomiphene-induced cycles, only 2 showed a continued E2 
rise. This compared unfavourably with unstimulated cycles where 
in 3 of 4 subjects the E2 levels continued to rise. 
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TABLE 5.1: CASES THAT DID NOT PROCEED TO LAPAROSCOPY 
Abn.foll . growth Others Total 
---------------
------ -----
Clomiphene 5 4 * 9 
Unstimulated 1 ** 2 
----- -----
6 5 1 1 
~ote: * 1 trial, 1 flu, 1 matrimonial disharmony , 1 husband with 
rubella 
** Dense shadow in endometrium on u/s ?tb 
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TABLE 5.2: DAILY PLASMA ESTRADIOL (pg/ml) LEVELS PRIOR TO OOCYTE 
RECOVERY 
Days prior to oocyte recovery hCG Number of 
(iu) --------------
7 6 5 4 3 2 1 0 foll. oocytes 
Clomiphene-induced cycles: 
-- ----- -------------------
1 • 337 207 189 766 1014 5000 2 1 
D14 015 
2 . 640 880 1892 2067 2119 1 61 4 5000 2 1 
D11 D12 
3 . 451 672 644 871 694 971 2 1 
013 
4 . 1 95 320 399 478 331 638 1045 763 5000 2 2 
D13 014 
5 . 505 978 1500 1255 1 1 
013 
6 . 232 408 396 795 1085 1152 1073 5000 3 1 
D15 016 
1 2 7 
TABLE 5.2: DAILY PLASMA ESTRADIOL (pg/ml) LEVELS PRIOR TO OOCYTE 
RECOVERY (continue) 
Days prior to oocyte recovery hCG Number of 
(iu) --------------
7 6 5 4 3 2 1 0 foll . oocytes 
Unstimulated cycles: 
-------------------
7. 190 229 381 453 588 629 1 
D16 
8. 11 7 475 645 422 1 
D12 
9. 87 87 56 128 1 32 1 76 229 451 1 1 
D16 
1 0. - 1 23 1 39 267 388 390 5000 1 1 
D12 D13 
128 
TABLE 5.3: PLASMA ESTRADIOL LEVELS (pg/ml) PER FOLLICLE IN 
CLOMIPHENE-INDUCED CYCLES · 
Patient 
7 
1 • 
2. 
3. 
4 . 1 95 
5 . 
6. 
Day prior to oocyte recovery 
6 5 4 
1 69 
320 440 
226 336 
160 200 239 
505 
77 136 132 
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3 2 0 
104 95 383 507 
946 1034 1060 807 
322 436 347 486 
166 319 523 382 
978 1500 1255 
265 362 384 358 
TABLE 5.4: MEAN ESTRADIOL VALUES (pg/ml) PER FOLLICLE IN 
CLOMIPHENE-INDUCED AND UNSTIMULATED CYCLES 
Day prior to oocyte recovery 
7 6 5 4 3 2 1 0 
Clomiphene-induced cycles: 
Mean values 195 154 219 304 361 537 700 633 
Std.deviation (+/-) 150 338 381 474 344 
Dnstimulated cycles: 
~ean values 87 105 121 179 217 342 463 473 
Std.deviation (+/-) 72 142 145 191 107 
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CHAPTER 6: 
FOLLICULAR PHASE IN CLOMI·PHENE-HUMAN MENOPAUSAL GONADOTROPIN 
CYCLES 
SYNOPSIS 
Two clomiphene-hMG regime s were compared. Clomiphene 50mg b.d. 
was administered from day 2 for 5 days while hMG was given from 
day 6. In the first regime 1 ampoule {75 iu) per day was given 
for the first 3 days, and in the second, 2 ampoules (150 iu) per 
day. The subsequent dosages were dependent on the E2 response. 
There were 9 cases for the first regime, and 10 cases for the 
second. The mean number of hMG ampoules given were 16.50 and 
19.25 respectively. The follicles seen on ultrasound were 3.0 + 
0.5 and 3.4 !-2 respectively. There was no statistical dif-
ference in the E2 response up to the day of laparoscopic egg 
recovery for the two regimes. However, spontaneous LH surge was 
observed in 4 of 9 cases in the first group and 6 of 10 cases in 
the second group. When a comparison was made between cases that 
had a spontaneous LH surge and cases that were given hCG there 
was a higher E2 level on the day of the laparoscopy in the hCG 
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group with the lower hMG regime (p<O.OS). There were no other 
differences . 
A 52.6% incidence of spontaneous LH surge with clomiphene-hMG was 
observed. Hence such stimulated regimes can result in a high 
proportion of spontaneous LH surges. This may be an index of 
satisfactory endocrinological control in spite of an increase in 
the number of follicles. 
INTRODUCTION 
The hMG regime was first used for IVF & ER by Steptoe and Edwards 
(1979), but was successfully implemented only in 1981 (Johnston, 
Lopata, Speirs et al, 1981; Jones, Jones, Andrews et al, 1982). 
Since then, there are many hMG regimes used all over the world. 
The use of hMG induces multiple follicular development and hence 
more eggs may be recovered at laparoscopy. A higher number of 
embryos replaced results in a higher pregnancy rate 
(Trounson and Wood, 1981; Biggers, 1981; Muasher, Wilkes, Garcia 
et al, 1984). However, fears have been expressed of shortened 
luteal phase (Johansson and Gemzell, 1969) and increased abor-
tion rates (Edwards and Steptoe, 1983) when the E2 levels in the 
follicular phase become too high. This is particularly so when 
132 
hMG is used (Olson, Rebar, Schreiber et al, 1983). 
A combination of an anti-estrogen such as clomiphene citrate 
with hMG has also been used with some success (Seppala, 1985). 
Laufer, de Cherney, Haseltine and co-workers (1983) believed that 
clomiphene may have negative effects on the ovum and corpus 
luteum. However , clomiphene has been used very successfully in 
IVF (Trounson, Leeton, Wood et al, 1981; Edwards and Steptoe, 
1983). Moreover, it is possible that clomiphene in combination 
with hMG may protect against shortened luteal phase seen in hMG-
induced cycles (Edwards, 1985). 
It is preferrable for E2 in the follicular phase to approach non-
stimulatory levels (Jones, Acosta, Andrews et al, 1983). When the 
clomiphene-hMG regime in KK Hospital was started, it was to 
determine whether lower doses of hMG in the initial stages 
resulted in such an E2 response. The Norfolk group has used hMG 
at 2 or 3 ampoules a day for the first 2 days of treatment and 
found that the higher dose resulted in more preovulatory oocytes 
but lower pregnancy rates (Jones, 1984). This chapter presents 
experiences with either 1 or 2 ampoules of hMG in the first 3 
days of hMG administration. 
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MATERIALS AND METHODS 
The clomiphene-hMG regime started in September 1983 (phase II). 
The stimulation regime and monitoring were described in Chapter 
3. 
The first 10 consecutive cases were assigned to regime I (lower 
hMG dose), and the next 10 cases to regime II (higher hMG dose). 
Unfortunately one 40 year old patient in the first group had ab-
normal follicular development and was excluded. She also had 
similar follicular phases in 2 previous cycles, one with 
clomiphene alone and another unstimulated. The patients' ages 
ranged from 29 to 40 years old (mean: 33.6 years) in the first 
group, and from 29 to 36 (mean: 33.0 years) in the second. 
Their indications for IVF & ER were tubal (7 in each group), 
tubal and oligospermia (2 in the second group), and prolonged 
idiopathic subfertility (2 and 1 in the first and second groups 
respectively). 
Statistical analysis was done using the Student's t-test. 
RESULTS 
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The mean number of hMG ampoules given in regime I was 16.5 (range 
4- 29) and 19.25 in regime II (range 13- 31 ). The mean number 
of follicles seen ultrasonically on day 9 was 3.0 in regime I 
(range 2- 4) and 3.4 in regime II (range 1 - 5). The ultrasonic 
observation of follicle number was used here because pelvic adhe-
sions prevented the determination of follicle numbers laparos-
copically in 3 patients in the first group and 6 patients in the 
second group . The mean day of laparoscopy was on 14.6 for regime 
I (range 12 - 16) and 13.4 for regime II (range 12 - 15). There 
were no statistical differences between hMG dosages, number of 
follicles observed on ultrasound, and the day of laparoscopy be-
tween the two regimes. 
The mean plasma E2 values are given in table 6.1. The values be-
tween the two regimes were not significantly different, p>0.05 
(figure 6. 1 ) • 
Spontaneous LH surge occurred in 4 of 9 patients in the first 
group, and in 6 of 10 patients in the second group. When the 
results were analysed according to whether spontaneous LH surge 
occurred or hCG was given, there was no significant difference 
between the E2 levels in the 2 regimes (figures 6.2 and 6.3), ex-
cept for the value on the day of laparoscopic recovery in regime 
I (6.2). The mean E2 level on that day was 606.9 ±254.9 (M ± 
1 35 
SO) pg/ml/foll for the group where hCG was given, as opposed to 
270.6 ~41.6 pg/ml/foll for the group with spontaneous LH surge 
(p<0.05). There was also no significant difference in the hMG 
dosage, number of follicles observed and the day of laparoscopy 
between the 2 groups in each of the two regimes . 
In spontaneous LH cycles more hMG was required, resulting in more 
follicles but lower levels of E2 per follicle . However, these 
observations were not statistically significant (p>O.OS) . 
Laparoscopy resulted in 9 eggs from 6 patients from regime I , and 
14 eggs from 6 patients from regime II . Those unsuccessful cases 
had severe pelvic adhesions . Fertilization and cleavage were seen 
in 5 eggs in the first group , and 9 eggs in the second . Embryo 
replacement was carried out in 4 patients from regime I , and 5 
patients from regime II . One pregnancy resulted from regime II, 
and has since delivered a normal term infant . 
DISCUSSION 
There was no statistical difference between the 2 regimes . In 
fact, despite increasing the FSH dosage during days 6 to 9 
(regime II), a higher mean total hMG dose was required. 
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The difference in the E2 levels on the day of laparoscopic egg 
recovery between the spontaneous LH group and hCG group noted in 
regime I was not observed in regime II. This observation may 
therefore not be important since a bigger series may not show 
this difference. 
For an IVF program, pregnancy rates appear to be better if E2 
levels continue to rise after a spontaneous LH surge or after in-
jection of hCG (Jones, Acosta, Andrews et al, 1983). Unstimu-
lated cycles are more likely to show a continued E2 rise than 
clomiphene-induced cycles (Ng, Ratnam, Yeoh et al, 1985). For the 
two clomiphene-hMG regimes, the mean E2 level fell after spon-
taneous LH or hCG injection. 
The literature suggests that it is not often that a spontaneous 
LH surge occurs in a cycle treated with hMG alone (Ferraretti, 
Garcia, Acosta et al, 1983; Laufer, De Cherney, Haseltine et al , 
1983). In fact there was no LH surge noted in 191 cycles treated 
in the Norfolk program (Ferraretti, Garcia, Acosta et al, 1983). 
However, in IVF cycles treated with clomiphene-hMG there is a 
variable degree of spontaneous LH surge (Trounson and Wood, 
1984). We had a high incidence of spontaneous LH surge, 4 of 9 
cycles from regime I and 6 of 10 from regime II. The timing of 
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hCG adminstration affected the frequency of spontaneous LH 
surges, and inversely the day of laparoscopic recovery . The ef-
fects of shortening the follicular phase by adminstrating the hCG 
injection earlier on the quality of the oocytes recovered were 
discussed in chapter 7 . 
Edwards and Steptoe (1983) reported that clomiphene treated 
cycles with spontaneous LH surges were better than clomiphene 
treated cycles with hCG for IVF successes. They suggested that 
the LH surge was more "physiological " than the hCG injection and 
this resulted in embryos or uteri superior for implantation. 
However, with their clomiphene- hMG series, the data suggested 
that the better embryos were from patients given hCG , and not 
those with spontaneous LH surge (Edwards, 1985 ) . On the other 
hand, Trounson and Wood (1984) , who had been using clomiphene 
with hMG since 1981, had an incidence of 62.0% spontaneous LH 
surge with the 305 patients so treated, and 63 . 8% of their embryo 
replacements and 76.7% of their pregnancies came from this group. 
Our series showed a 52 . 6% incidence of spontaneous LH surge with 
clomiphene-hMG . There was one pregnancy in 5 replacements in 
regime II , but no pregnancy in 4 replacements in regime I . After 
completion of this study we continued with regime II because of 
higher number of follicles and earlier laparoscopic recovery day . 
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Such stimulated regimes can result in a high proportion of spon-
taneous LH surges with resulting pregnancies. This may be an in-
dex of satisfactory endocrinological control in spite of an in-
crease in the number of follicles. 
However, the presence of spontaneous LH surge results in logistic 
difficulties in many IVF programmes. This is due mainly to the 
short notice for egg recovery after the detection of the onset of 
the LH surge. Many IVF programmes cancel such cases. In fact, 
there is now a tendency to suppress the spontaneous LH surge by 
down-regulation of the pituitary with analogues or antagonists of 
gonadotropin releasing hormone (Sharma, Williams, Whitehead et 
al, 1986). This is further discussed in chapter 8. 
It is possible that clomiphene-hMG cycles for IVF offer advan-
tages over hMG cycles without clomiphene. Firstly, there is an 
increased likelihood of spontaneous LH surge. Logistically, this 
may not be an advantage , but it is likely to be more physiologi-
cal. Secondly, the anti-estrogenic effect of clomiphene may 
protect the corpus luteum from early luteolysis (Trounson and 
Leeton, 1982), thus decreasing the possibility of a short luteal 
phase. Thirdly, clomiphene may also protect the endometrium from 
the high estrogenic levels reached with such stimulation. Exces-
sive estrogenic stimulation results in abnormal endometrial 
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growth (Novak and Woodruff, 1979). Clomiphene binds to estrogen 
receptors in the female genital tract and the receptor complex is 
retained in the nucleus for long periods (Edwards, 1980). 
Fourthly, there is a possiblity of better pregnancy rates 
(Trounson and Wood, 1984)). This needs further verification as 
there seems to be conflicting data by Edwards (1985). Fifthly, 
there is no need for hMG administration in the early follicular 
phase, and this is an advantage when patients come from overseas 
for treatment. 
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TABLE 6.1: MEAN PLASMA ESTRADIOL LEVELS (pg/ml) PER FOLLICLE IN 
CLOMIPHENE-HUMAN MENOPAUSAL GONADOTROPIN CYCLES 
hMG . Foll. Day prior to oocyte recovery 
(amp) 
Regime I : 
--------
M 6.5 3.0 
so 7.0 0.5 
n 9 9 
Regime II: 
M 19.25 3.4 
so 6 . 0 1 • 2 
n 1 0 10 
8 7 6 5 4 3 2 1 0 
84.0 153.6 222.8 225.4 303.4 397.9 595.2 589.9 457.4 
10.9 34.8 72.3 50.6 128.0 139.9 255.4 243.2 254.1 
4 6 7 8 8 9 9 9 9 
113.9 135.5 179.4 257.3 340.0 534.9 661.8 479.5 
41.9 63.2 75.8 101.9 126.9 174.1 208.6 181.6 
2 4 8 1 0 1 0 1 0 1 0 9 
1 41 
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CHAPTER 7 
EARLIER ADMINISTRATION OF HUMAN CHORIONIC GONADOTROPIN 
SYNOPSIS 
The most common r e gime for follicular stimulation in IVF 
programmes is clomiphene-hMG. For the final maturation, hCG is 
usually administered. It was investigate d whether hCG given ear-
lier resulted in better egg quality for IVF. hCG (10,000) iu was 
given when the E2 was either 700 or 500 pg/ml/follicle. There 
was an increased likelihood of spontaneous LH surge when hCG ad-
~inistration was delayed; spontaneous LH surge occurred in 8 of 
27 cycles in the group where hCG was to be given when E2 was 500 
Dg/ml/follicle (IVF 500), and in 14 of 22 cycles when E2 was 700 
Dg/ml/follicle (IVF 700) (p<O.OS). Of the 22 cycles in the IVF 
tOO group, 66 eggs were obtained. Thirty-five (53.0%) were mature 
~nd 26 (39.4%) were intermediate, as judged morphologically. Of 
the 27 cycles in the IVF 500 group, 92 eggs were obtained; 55 
(59.8%) were mature and 36 (39.1%) intermediate. Hence there 
were more preovulatory eggs (mature + intermediate) when hCG was 
~iven e arlier (92.4% for the group where hCG wa s given at 700 
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pg/ml/follicle, compared with 98.9 % for the 500 pg/ml/follicle 
group; p<0.02). However, when spontaneous LH cycles were ex-
cluded, all the eggs were preovulatory for both the IVF 500 and 
700 groups. Fertilization and cleavage were seen in 39 of 61 
(63.9 %) preovulatory oocytes in the IVF 700 group, and 42 of 91 
(46.2%) in the IVF 500 group (p<O.OS). Again when spontaneous LH 
cycles were excluded, there was no difference in fertilization 
and cleavage between the 2 groups. There was thus no difference 
in preovulatory egg morphology and quality in earlier administra-
tion of hCG in this clomiphene-hMG regime. 
lNTRODUCTION 
Follicular stimulation is one of the more critical aspects in any 
IVF program because it determines the egg quality. There are 
many regimes for follicular stimulation as discussed in earlier 
chapters, the most common being clomiphene-hMG (Seppala, 1985). 
In most stimulation regimes, hCG is usually administered for the 
final maturation (Seppala, 1985). However, some IVF centres 
still monitor for spontaneous LH surge, in the belief that this 
results in better ~uality eggs (Edwards, 1985). The incidence of 
LH surge is dependent on the stimulation regime and the duration 
before hCG is administered (see Chapter 6). Too early administra-
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tion of hCG may result in premature luteinisation (see Brown, 
1986); moreover, inadequate luteinization occurs due to lack of 
sufficient LH receptors (Channing and Kammermann, 1973). If hCG 
is administe red too late, spontaneous LH surge may result and 
this is logistically unsatisfactory for many centres. We there-
fore investigated whether hCG given earlier resulted in better 
egg quality for IVF. 
Anothe r aspe ct in hCG administration is the length of the coast-
ing pe riod (ie the duration between the last hMG injection and 
the hCG inj e ction). This was studied by Luafer, deCherney, Tar-
latzis e t al (1984). They reported that delaying the hCG injec-
tion af t e r hMG stimulation from 24 hours to 48-72 hours resulted 
in poo r er fe rtilization (57 % versus 84%) and an increase in 
Oege ne r a t ed oocytes (9% ve rsus 1%). 
~ A D METHOD 
~atients in this study were f r om a subset of phase II, the 
St· l.rnul tion an monitoring of which we re discussed in Chapter 3. 
lienc h chara cteristics of this sample is only n mph sis on t e 
9iv n h r . n tw n ov mber 1983 a nd June 1984, 27 patients 
7 . 1 ) w stimul t 
wi th c lomi ph e ne citrate at 50 mg 
1 4 7 
twice a day from day 2. hMG was then administered in the after-
noon at 2 ampoules per day from day 6 to 8. Subsequent doses 
were dependent on the plasma E2, taken daily at 0830 hours. The 
patient was admitted when the E2 level reached 400 
pg/ml/follicle. In the absence of spontaneous LH surge, hCG 
10,000 iu was given early the morning after admission if the 
Plasma E
2 
exceeded 700 pg/ml/follicle; a "coasting" period of at 
least 32 hours was allowed. 
The second group of 30 patients (table 7.1) were recruited be-
tween July 1984 and December 1984. The stimulation and monitor-
ing regimes were similiar. HCG was given at 500 pg/ml/follicle in 
the absence of the LH surge. 
Insemination of the eggs and culture of the embryos have been 
described in Chapter 3. 
Th d d t t 1'stl'cally using the Student's t-test. e ata were analyse s a 
'l'he 
me n numb r 
tVr soo n IVF 
of hMG ampoules needed were 13.7 and 17.6 for the 
S respectively (p<0.05). The mean day 70 0 group 
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for laparoscopy was 13.2 and 13.3 respectively (n 0 05) 
.s.; p> • . 
Plasma E2 levels reached 631 pg/ml/follicle and 682 pg/ml/ 
follc1'le for the IVF 500 and IVF 700 groups respectively (ns; 
P>0.05, table 7.2). 
Spontaneous LH surge occurred in 8 and 14 cycles in the IVF 500 
and IVF 700 groups respectively (p<0.05). As expected, the E
2 
Values were higher on the day hCG was administered in the IVF 
7oo group (955 ~168, as opposed to 690 ~196 pg/ml/follicle for 
lVp 500 ; p<0.001 ). There was no such difference when spontaneous 
LB surge occurred. 
1here were more preovulatory eggs (mature and intermediate types) 
in the IVF 500 group (p<0.02, table 7.3), reflected mainly in an 
increase in mature eggs (59.8% as opposed to 53.0% in the IVF 
loo group) . Howe v e r , when eggs recovered after spontaneous LH 
surge we r e e xclude d, there were less mature eggs when hCG was 
Sl.', osed to 79 2% in the IVF 700 group). ve n earli e r ( 6 4 . 7% a s opp • 
~U t there we r e no i mma ture eggs obtained when spontaneous LH 
~Ycl es were excl uded . 
lt) t h the fe rtilization rate was less (46.2% of IVF 500 gro up , 
heo ul comp r ed with 63 . 9% in the IVF 700 group, tory gs 
t~b l 
7 . 4 ; p<0 . 05 ) . Wh en the r e was no spont neous LH surge, fer-
14 9 
tilization and cleavage rates were similiar regardless of timing 
of hCG administration . 
There we re 3 pregnancies in each group ( table 7 . 4) but the num-
bers we re too small for statistical evaluation . It was interest-
ing to note that the pregnancies in the IVF 500 group were after 
hCG administration, while 2 of the 3 pregnancies in the IVF 700 
group were after spontaneous LH surge . 
QlSCUSSION 
Prom the data it is clear that the incidence of spontaneous LH 
surge is dependent on when hCG is administered ; the longer the 
delay , the more the likelihood of spontaneous LH surge . This may 
explain why spontaneous LH surges vary from 3-85% , with the 
~edian at 20 % (Seppala , 1985) . Trounson and Wood (1984) reported 
an LH surge incidence of 62 . 0% in clomiphene- hMG stimulated 
~Ycles . 
SPontaneous LH surge resulted in eggs with better fertilization 
tates ( 56 . 0% as opposed to 42 . 6% when hCG was given in the IVF 
Soo group , nd 66 • 7% as opposed to 45.8% in the IVF 700 group; 
~s 
I table 7. 4). However, the re were no pregnancies in 8 re-
150 
place ments with spontaneous LH surge in the IVF 500 group, while 
there were 2 pregnancies in 13 replacements in the IVF 700 group 
when spontaneous LH surge occurred. Trounson and Wood (1984) 
r eported tha t the pregnancy rate per transfer with spontaneous 
LH surge was 23.1 % as opposed to 12.3% when hCG was ad-
ministered . The World Collaborative report showed that preg-
nancy r ate was 15.6% with LH surge and 9.8% with hCG in 
clomiphene -hMG regimes (Seppala, 1985). 
Steroidal contents of follicular fluid show definite patterns of 
change evident towards ovulation, including a decrease in E2 and 
an inc r ease in p (see Edwards , 1980). Such changes are also seen 
in follicular fluid following hCG administration; Templeton 
(19 85) reported a decrease of E2 and androstenedione to 30% of 
Pre-hcG levels , with a four-fold increase in P. Hence the micro-
environment of the follicle is probably steroidogenically 
Similiar following an e ndogenous LH surge or hCG administration. 
~his h s significance in the morphological grading of eggs col-
lected . 
Morphologic 1 appearance of the cumulus a nd corona has been used 
to ss ss the m turity of the egg . Unfortunately , it is not rep-
tesent tiv of the egg maturation sta tus (La ufer, Tarlatzis, de 
Cherny 
84
. S strom and Nilsson , 1986). Howe ver, it is 
l , 1 9 , un 
1 51 
still use ful for assessing egg quality in any particular regime. 
Our data suggested that spontaneous LH surge resulted in more 
intermediate-quality eggs (12 of 25 [48.0%] in the IVF 500 
group, and 21 of 42 [50.0 %] in the IVF 700 group, ns; table 7 • 3 }. 
Also , in the absence of spontaneous LH surge, hCG administration 
resulted in more mature eggs morphologically, with more mature 
eggs obtained when there is a longer delay in hCG administration 
( 44 of 68 [64 .7 %] in the IVF 500 group, and 19 of 24 [79.2 %] in 
the IVF 700 , p>0 . 05} . This was not surprising since it has been 
reported that longer hCG-collection interval resulted in better 
egg recoveries, probably due to cumulus expansion (Templeton, 
1985) . However , in the mouse we have demonstrated that a shorter 
interval in collection after hCG did not result in poorer quality 
eggs ( E irisinghe , Law , Ng et al, 1986}. In the absence of spon-
taneous LH surge , there was no statistical difference in fer-
t. . lllzation and cleavage between the 2 groups (11 of 24 and 29 of 
68 for IVF 700 and 500 respectively, table 7.4). 
tn H rge is dependent on E2 (Young and natur 1 cycles , the L su 
Jaff 
e , 197 6 ; M rut , Williams , Cowan et al , 1981 ), produced 
ntainly by th omin nt follicle . In stimulated cycles, addi-
ti 0 · ovarian follicles may result in na1 r cruitment of developl ng 
d Kenigsburg , Collins Ho gen , etal, 1985}. qn Un e v n cohort (see 
ug 
of closer cohort with hCG administration 
w tiv 
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in both the IVF 500 and IVF 700 groups . Hence it is possible 
that when spontaneous LH surge occurs, there may be a widening in 
egg maturity between the dominant follicle and the rest. 
However , it must be noted that while the maturity of the egg may 
be more advanced with hCG administration , fertilization and 
cleavage r ates were better with spontaneous LH surge. Testart, 
Prydman, de Mouzon et al (1983) reported that the egg population 
was not homogenous when hCG was given . 
!n conclusion , spontaneous LH surge was more likely to occur when 
hcG administration was delayed . HCG administration resulted in 
more mature eggs assessed morphologically, but the incidence of 
fertilization and cleavage was less than in eggs recovered after 
Spontane ous LH surge . 
min· 
tstra tion did not 
In this clomiphene-hMG regime, earlier ad-
result in a change in the number of 
Preovul t f rtl'lization and cleavage rate. a ory eggs or e 
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TABLE 7.1 : AETIOLOGY OF INFERTILITY AND AGE OF PATIENT VERSUS hCG 
ADMINISTRATION 
PATIENT hCG ADMINISTRATION 
IVF 500 (%) IVF 700 (%) 
----------
1 • Aetiology : 
Tubal 1 7 
(56.6) 17 (63.0) 
Tubal & oligospe rmic 6 
(20.0) 3 (11.1) 
Oligospermic 3 
(10.0) 4 (14.8) 
Idiopathic 
2 6. 7) 1 3. 7) 
2 6 . 7) 2 7. 4) 
Others 
30 27 
2. Age ( y rs) : 
1 7 (56.7) 20 (74.1) 
35 an less 
1 3 (43.3) 7 (25.9) 
>35 
1 54 
TABLE 7.2: MEAN PLASMA ESTRADIOL LEVELS (pg/rnl) PER FOLLICLE FOR 
PATIENTS WITH HUMAN CHORIONIC GONADOTROPIN AT DIFFERENT 
LEVELS 
hCG 
GROUP 
!VF 500 - M 
so 
!Vp 700 - M 
so 
Day prior to egg recovery @ 
--------------------------------------
7 6 5 4 3 2 1 0 
82 124 171 224 346 527 631 399 
20 32 53 64 105 154 197 128 
104 124 173 261 364 542 682 529 
28 38 74 113 143 205 255 224 
~ b t t'st1'cally significant between IVF 500 ~ ~strad iol va lue s not s a 1 
and IVF 700 (p>O.OS) 
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TABLE 7 . 3 : EGGS COLLECTED FROM PATIENTS WITH HUMAN CHORIONIC 
GONADOTROPIN AT DIFFERENT LEVELS 
EGG TYPE * 
---------
Mature 
lntermediate 
lrnmature 
n 
LH 
1 1 
1 2 
1 
25 
8 
IVF 500 
hCG 
44 
24 
0 
68 
1 9 
subtotal 
55 
36 
1 
92 
27 
LH 
1 6 
21 
5 
42 
1 4 
IVF 700 
hCG 
1 9 
5 
0 
24 
8 
subtotal 
35 
26 
5 
66 
22 
Oocyte types of IVF 500 and IVF 700 * p<0 . 02 between 
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TABLE 7.4: EGGS FERTILIZED FROM PATIENTS WITH HUMAN CHORIONIC 
GONADOTROPIN AT DIFFERENT LEVELS 
IVF 500 IVF 700 
-----------------------
LH hCG subtotal LH hCG subtotal 
Eggs coll * 25 (8)+ 68 (19) 92 (27) 42 (14) 24 (8) 
Pertilization 14 (8) 29 (13) 43 (21) 28 (13) 11 (8) 
!?regnancies 0 3 
2 1 
~ p<O.o 5 between pre-ovulatory eggs and fertilization of 
IVF 500 and IVF 700 
~ number of patients in parenthesis 
1 57 
66 (22) 
39 (21) 
CHAPTER 8: 
SPONTANEOUS LUTEINIZING HORMONE (LH) SURGES 
§INOPS IS 
The pre s e nce of spontaneous LH surge is thought to be related to 
bette r pregnancy rates in clomiphene-hMG induced IVF cycles. LH 
in the urine has been easily detected with Hi-Gonavis. A 
r e trospective analysis of 54 IVF cycles in which urine LH assayed 
by a microtitre method using Hi-Gonavis was compared to plasma LH 
a ssayed by RI A. The false negative rate was 7.4%, while the false 
Pos i tive r a t e was 16 . 7% In the false negative group, hCG was 
9ive n, af t e r the LH surge in the plasma in all cases. Only 2 eggs 
we r e col l ec t ed f r om 1 patient and both fertilized ; none were col-
l e c ted f r om the o the r 3 patients because of spontaneous fol-
licula r rupture prior to laparoscopy . In the false positive 
9r oup , 23 e ggs were r e cove r ed from 9 patients . Fifteen (65 %) of 
them we r m ture , nd t hese fe rtilized and cleaved. On the other 
hand , in th true posi t i ve g roup (13 patients , 33 eggs ), only 12 
~99s ( 36 ) we r e m ture , a nd 19 (58 %) fertilized and cleaved. The 
Poor r r esults m y be d ue t o the absence of hCG injection. 
t ~ 
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The release of endogenous gonadotropins is dependent on the pul-
satile action of the hypothalamic GnRH on the pituitary. Hence 
its release is also cyclical (see chapter 2). However, when the 
negative feedback of E2 on the hypothalamus is converted to a 
positive feedback, there is a massive release of LH seen as a 
surge . Such surges differ in pattern in different species. In 
rats, there is a slow initial rise of LH followed by a linear in-
crease to a peak persisting for about 2 hours (Blake, 1976). In 
mares , LH rises gradually throughout the cycle without a distinct 
surge , and ovulation occurs while the LH levels are still in-
creasing (Nett, Pickett , Seidel et al, 1976). In women, the mid-
cycle surge typically begins with a modest increase in plasma FSH 
and LH followed by a dramatic rise and an equally rapid fall . The 
LB peak is actually 2 peaks separated by an interval of 12-24 
hours, with the whole discharge over in 30 hours (Edwards, 1980) 
!t is thought that the LH surge overcomes the locally inhibiting 
non-steroidal follicular factors preventing premature oocyte 
~atur tion , such as the oocyte maturation inhibitor, OMI 
(Tsafriri , B r-Ami and Lindner , 1983). Approximately 20 hours 
qfter th 1·s in _vivo resumption of oocyte L!I surge , there 
~atur of meiosis from prophase of meiosis I 
tion ; re-activation 
tesu ts in extrusion of the first polar body between 25 and 35 
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hours after the LH surge ( Edwards , 1980; Steptoe and Edwards, 
1970; Testart , Thebault and Frydman , 1982b) . The egg is then at 
me taphase II and is ready for fertilization by the sp~rm . These 
events can also be initiated by hCG , but its timing is important 
(see chapter 7) . The significance of a spontaneous LH · surge 1n an 
IVF program has also been discussed ( see chapter 6 ). 
Whil e the LH surge has classical l y been detected with blood 
studies , it can also be detected in the urine , where it occurs 
soon after the surge in plasma . Urinary samples are preferred by 
the patients, and are usually c o llected over 24 hours . Immunoas-
says and receptor assays are widely used . Another fast assay 
method us ed clinically is an erythrocyte sedimentation assay {Hi -
Gonavis , Mochida , Tokyo) , which can be completed in 2-3 hours 
(Mi zuno , a wamoto, Mizukuchi et al , 1973 ; Yoshimoto , Moridera and 
lmura, 1974) . Edwards , Anderson , Pickering et al ( 1982 ) have 
modified it into a micro titre method which has been claimed to be 
equally effective . The purpose of this chapter is to analyse data 
on the use of Hi-Gonavis for the detection of the spontaneous LH 
sur e . 
~ AND METHOD 
~n n lysis of 54 p tients in phase II where there was adequate 
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plasma to determine the LH levels by radio-immuno-assay was made . 
The radio-immuno-assay method for LH has been previously 
described (Goh , 1981 ), and the incubation period takes 24 hours; 
the samples were collected together and analysed retrospectively . 
Only the Hi-Gonavis results were available for clinical decisions 
in the management of the patient . The stimulation and the 
monitoring have been dealt with in chapter 3 . 
The Hi-Gonavis assay is a kit assay which involves a step-wise 
dilution of urine . It is based on haemagglutination . If there is 
sufficient hCG or LH in the urine, the sheep erythrocytes ag-
glutinate, and this modifies their sedimentation pattern in the 
ampoules . A positive reaction is seen as a smooth mass of cells 
at the bottom of the ampoule in 2 hours . The assay is sensitive 
to 12 . 5 iu LH or 5 . 0 iu hCG . A microtitre method was later 
devised , resulting in a four-fold savings of cost (Edwards, An-
derson , Pickering et al , 1982) . Tissue-culture grade microtitre 
Plates we re used . The urine was diluted with phosphate-buffered 
8olution at a concentration of 65 ul of urine with 40 ul of PBS . 
Then 40 ul of the mixture was trans fe rred into the next well and 
~ixed with 25 ul of PBS , and this procedure was continued down 
the wells . The sensitized erythrocytes (100 ul) were then added 
int t't t 1'ng in PBS containing bovine o the wells after recons 1 u 
bumin . The wells were then shaken and l ef t to stand for 2 
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hours. It was claime d that this method was more r l ' bl d e 1a e an gave 
narrower serial dilutions , with greater precision. 
Sta tistical ana lysis was carried out using the ch; s t t 
4- quare e s . 
RESULTS 
Of the 54 cases , there were 13 true positives (24.1 %) and 28 true 
negatives (51.8 %) (table 8.1 ). Four cases were false negatives 
(7.4 %), while 9 were false positives (16.7%) 
ln the false negative group, hCG was given after the plasma LH 
surge because there was absence of the LH surge as detected by 
Hi-Gonavis . of the 4 patients, 3 h~d spontaneous ovulation con-
firmed at laparoscopy and no eggs were recovered from them. In 
the 1 patient where there was no spontaneous ovulation, 2 eggs 
were recovered ; one was mature and the other intermediate in 
quality . Both fertilized after insemination. 
0f the 9 f lse positives , where there was no hCG given, the 
~ajority w r pre-ovula tory (1 5 mature , and 5 intermediate, of 23 
e99s ) . Only th 15 m ture eggs fertilized (table 8.2). 
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In the true positive group (13 patients), where there was no hCG 
given , 12 of 33 eggs (36.4 %) were mature, 16 intermediate and 5 
poor (table 8.2). However only 19 fertilized (57.6 %). 
In the true negative group, there were 72 eggs from 28 patients. 
The majority (53 of 72) were mature, and 15 were intermediate 
eggs . However , the fertilization rate was the lowest (48.6%). 
There were 4 pregnancies in this sample population, in 36 re-
Placements (8.3 %). Two were from the true positive, and 2 from 
the true negative groups . 
£!§cuss roN 
ln the true positive group , all patients (with one exception) had 
th col.·ncidental with the detection of LH in the 
e pl a sma LH rise 
ur· had an increase in plasma LH one day earlier 
lne . One pa ti e nt 
th At l a paroscopy 3 follicles were already 
an the Hi-Gona vis rise . 
~he 
~ow 
, a n 
n 
Hi- o n v i 
1 
unruptured folli cle yielded 1 egg which fer-
iv i e to 4 cells . 
high false positive of 16.7%. 
55 y gave a 
v r , 65 of t h 
covered from this group were mor-
ggs r e 
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pholog ically mature and were able to fertilize . Not surprisingly , 
the r e we re no pregnancies in this group . Using Hi-Gonavis to 
de t e ct LH surges in spontaneous cycles , Edwards and Steptoe 
(1974) reported failure in egg recovery of 35% , while Lopata , 
John s ton , Hoult et al (1980) reported a failure rate of 44% . 
In spite of hCG injection, the true negative group had the lowest 
f e rtil i z a tion rate of 48 . 6% . It is possible that the hCG ad-
mini s tra tion could have been too early in the majority of these 
ca s es . This was in contrast to other studies where hCG ad-
mini s tra tion r e sulte d in significantly improved embryo transfer 
artes ( Uma pa thysivam , Jones and Meffin , 1986 ). 
Because of the h igh fa lse positive and false negative rates in 
t he Hi-Gon vis ssay , it was decided not to rely on it . In fact , 
be~ f ~ us of th use o 
combination of FSH-hMG stimulation , spon-
taneous LH s rge re not de t e cted now , mainly because this regime 
ts suppos to h e 
low incidence of such surges . 
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TABLE 8.1: FALSE POSITIVES AND NEGATIVES WITH HI-GONAVIS 
Plasma LH Hi-Gonavis 
+ 
+ 1 3 4 {FN) 
9 {FP) 28 
-------------------------------
FN = False negatives, 4/54 {7.4%) 
FP =False positives, 9/54 {16.7%) 
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TABLE 8.2: QUALITY OF EGGS AND EMBRYOS OBTAINED CATEGORIZED AC-
CORDING TO SPONTANEOUS L.H. SURGE * 
HiG/Pl Eggs(n} Mature Inter Immat Poor Fert Unfert 
+!+ 
-!-
-!+ 
+/-
33 
72 
23 
2 
------
12(36%} 16(49%} 4(12%} 1(3%} 19(58%} 14(42%) 
53(74%} 15(21%} 4(5%} 35(49%) 37(51%) 
15(65%} 5(22%} 3(13%) 15(65%) 8(35%) 
1(50%} 1(50%} 2(100%) 
* Statistically no difference between different egg gradings. 
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CHAPTER 9: 
COMBINATION OF ULTRASOUND WITH ESTRADIOL 
§...YNOPSIS 
There are various regimes of ultrasound monitoring of follicular 
growth for IVF . The majority are dependent on sequential 
monitoring . In this chapter , it was examined whether frequent 
Ultrasonic moni toring of follicle growth is necessary for IVF . In 
Phas e I , 22 patients were stimulated with clomiphene citrate or 
were unstimulated , a nd had daily ultrasound scanning from day 8 • 
ln phase II , 28 patients were stimulated with clomiphene and 
hMG, and ultrasound scanning was reduced to once on day 9. Daily 
Ultr sound in phase I showed a significant correlation in fol-
licul r growth in clomiphene -induced patients with 1 and 2 fol-
licl s (p<O.OOl ), but there was no such correlation in unstimu-
lat p ti e nts . In spite of reducing the scanning frequency to 
1 
· h se II the numbers and side of follicles 
r eye e ~n p ' 
carr tly pre icted in 60% (6 of 10 laparoscopies), as op-
0 30 
o curr 
(
6 
of 20 lap roscopies ) in phase I . Spontaneous LH 
·n 13 of 25 ph se II patients ; the E2 values on 
1 67 
the day of the LH surge were higher when there were more fol-
licles (r=0.69). There were 7 preovulatory eggs of 11 eggs 
(63.6 %) aspirated from phase I patients with tubal obstruction, 
and 26 of 30 eggs (86.7%) in phase II; cleavage rates of these 
embryos after fertilization were similar (85.7% and 73.1% 
respectively ). Alhough pregnancy rates in patients with tubal 
obstruction were better in phase II (3 of 9 replacements) than 
in phase I (1 of 7 replacements), this was probably a reflec-
tion of multiple embryo replacement in phase II. It is concluded 
that it is not necessary to do frequent ultrasound scanning to 
monitor follicular growth for IVF patients stimulated with 
C::lomiphene-hMG . 
Monitoring of follicular growth is important in IVF programmes. 
Most b' t 1'on of ultrasound and E2 assays centres use a com 1.na 
(~rounson nd Conti , 1982) though some use either alone. 
0ltrasoun monitori ng as the only method of monitoring fol-
lic::ul r rowth has been reported by a few centres (Hoult, de 
Cre 1 1981 Li ttle , Bromwich, Walker et Spigny , O' Herlichy et ' ; 
~l 1 1 984) Bourn Hall clinic 
' 1983 ; Smith , Porter , Cr ft eta ' • 
ts on o f h v ry few centres using endocri ne parameters 
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(urinary estrogens) without ultrasound (Edwards , Steptoe and 
Purdy , 1980), although recently they are relying on ultrasound 
scans as well . 
There are various regimes o f ultrasound monitoring of follicular 
growth . Most centres begin monitoring by day 10 of the cycle, 
though some advocate adequate response (eg. by E2 ) before 
monitoring (Kerin, Edmonds , Warnes et al, 1981 ). Scanning can be 
done daily or intermittently . Sequential scanning gives a bet-
ter picture of follicular growth and change in its growth rate or 
achieving a minimum diameter or volume may be used as an index of 
maturity . Some IVF groups give hCG for final follicular matura-
tion on this basis (Hoult, de Crespigny, O'Herlichy et al, 
1981 ) . Intermittent scanning is adequate for IVF groups not 
telying on ultra sonic parameters of follicular maturation 
(Butte ry , Trounson , McMaster et al , 1983). Its use then may be 
Confine to etermi na tion of the number or the site of fol-
licles . Un er s uch ci rcumstances , follicular growth is monitored 
usually by E2 . 
'l'he 1 F pro r m 
KK Hospital had 2 main stimulation regimes . 
'l'he 
0 r so n 
t~9im 
w r h 0 
(~h 
I ) I n w 
foll 1·cular scanning in these 2 sc ns in 
inv stigate . For the first nine months 
im lated with clomiphene citrate or 
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were unstimulated, and were monitored with daily ultrasound 
scanning and daily plasma E2 from day 9. From September 1983 
(phase II) , patients were stimulated with clomiphene and hMG, 
and were monitored with daily plasma E2 from day 8; ultrasound 
scanning was reduced to once on day 9, and a repeat later if 
necessary . 
~TIENTS AND METHOD 
!n phase I , there were 22 patients involved in 33 patient cycles, 
with 22 laparoscopic recoveries . In phase II the first 28 
Patients (comparable sample size) in 28 cycles (with 25 laparo-
Scopic recoveries) were studied . The method of stimulation and 
monitoring have been described in chapter 3. 
~ scanning 
'l'his inly by one ultrsonographer throughout the period w s one m 
Of stu it was done daily from day 8, while in y . In ph se I 
Ph as was done once in day 9 and repeated (usually II sc nnin 
on Follicles above 5 mm were y 0 o r 11 ) if necess ry . 
c:oun m chine was a Hitachi linear array Th l r -soun 
rno l 3 . 5 mHz probe . UB 25 w h 
• 
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~tatistical analysis 
There was a gre at variation in the average follicle diameters . 
Hence, in the statistical analysis of folli c ular growth, the 
median values instead of the mean values were used . Th 
e correla-
tion was calculated using non-parametric methods (Spearmann's 
corre lation) . The regression equation was calculated for theE 
2 
levels at which spontaneous LH occurred . 
t he ver ge i me t e r o f follicle between patients . 
value reshown i n t a bl e 9 . 1 . In clomiphene-stimulated cycles , 
w s significant corre lation in growth pattern in patients 
~ith n 2 ollicles (p <0.001 ). For the 3 and 5 follicle 
Stoups , 
numb rs were too sma ll for meaningful interpretation . 
tn th cycles , t he r e wa s no such correlation in n im 1 
t> i sign ify i ng pe rhaps an unsatisfactory n w h 2 ollie! s , 
St0 ..., h h n . Thou h re w s corre lation for the unstimu-
l 
number of patients was too small 0 w h , oll cl I the 
1 71 
to draw any conclusion. 
The numbe rs and side of follicles were correctly predicted by 
ult rasound in 30 % (6 correct in 20 laparoscopies where the 
ovaries could be seen clearly) in phase I, and 60% (6 correct in 
10 laparoscopies) in phase II. This difference was not sig-
nificant ( n . s. ; Fisher 's exact probability test). There were 
severe adhesions in the other 15 laparoscopies done in phase II. 
Preovulatory eggs collected from patients with tubal obstruction 
were 7 of 11 eggs (63.6 %) in phase I, and 26 of 30 eggs (86.7%) 
in phase II ( p<0 . 05). The quality of the eggs was similar in 
both phases , as evidenced by cleavage rates of 85.7% (6 of 7) in 
Phase I and 73 . 1% (19 of 26) in phase II (ns, p<0.05)). Eggs 
Collected from patients with oligozoospermia and prolonged 
idiopathic subfertility were e xcluded because fertilization may 
be diminished in these 2 groups (Mahadevan, Trounson and Leeton, 
1983) Pregnancy r ates for patients with tubal obstruction were 
better in ph se II ( 33 . 3% , 3 of 9 replacements) than in phase I 
(l4 . 3 , 1 0 7 r pl cements ). 
Of h 1 paroscopy in phase I , 14 of 22 (63.6 %) c s h h 
ha 
s while in phase II , 13 of 25 (52.0 %) had on II ur e , 
sPon (n . s . ) · The E2 values on the day of spon-LH r 
n o II were higher when there were more in h s 
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follicles (figure 9.1 ), with a regression equation 
Y = 820.8 + 380.3X 
where Y = plasma E2 value (pg/ml) at which spontaneous LH surge 
Wou ld occur, and X = number of follicles on ultrasou d n scan on 
• , at 9 degrees of day 9 . The corre lation coefficient, r is 0 69 
freedom ( <0 05) p • • 
Q.Lscussio 
Pellicular growth patterns could be studied only in phase I. 
Unstimulated cycles did not show significant correlation in 
9rowth patterns , and this may indicate unsatisfactory follicular 
9rowth . Clomiphene-s timulated cycles with 1 and 2 follicles 
si nificant correlation in growth pattern. There were 
inad e u t e s mple sizes in clomiphene-stimulated cycles with more 
than 2 oll'cl s . The median diameters were much smaller in the 
Clomi h n e -in c cycle in which 5 follicles developed (table 
9 • 1 } • 
i 
c t c 0 
0 00 
r o w h corr lation patterns for phase I, the ac-
n 
0 
follicles (as confirmed by 
1 7 3 
laparoscopy) was only 30% . In phase II when the ultrasound scan 
was limited to day 9 , the accuracy was 60% . This improvement may 
be attributed to experience though there was significant growth 
coefficient in phase I for 1 and 2 follicles . Operator 
variabilty may have also been contributory ( Prins and Vogelzang, 
1984) . 
Spontaneous LH surge occurred in 52 . 0% of phase II patients . 
Based on the regression equation (figure 9 . 1 ) , it is possible to 
9ive hCG just before the anticipated spontaneous LH surge , 
the reby being closer to the natural state and yet minimizing the 
inconve ni e nc e of spontaneous LH surge . In unstimulated cycles , 
blood E
2 
l e ve ls can be used to predict the LH surge (Mcintosh , 
Ma the ws, Crocke r e t al, 1980) . However , in the presence of mul-
tiple f ollicles of dif fer e nt cohorts , daily ultrasound scans 
Should be able t o a nticipa te the likelihood of spontaneous LH 
su r g better th n E
2 
va lue s . Buttery , Trounson , McMaster et al 
(1 983 ) h e c lcul ted a r eg ression equation to determine the LH 
s . l.rnul 
b 
an ous LH 
se 
en h 
on th 
u u t 
wi h 
o E 
i mete r of the largest follicle. Levran , 
1 
(
1
985 ) r eported in a study of 117 women 
omiphen - h MG tha t in those cycles where a span-
oc rr 
' 
most s urges we r e detected on the 
i 
1 7 
The quality of eggs recovered was better in phase II when the 
ultrasound scan frequency was reduced to once-a-cycle; 86.7 % was 
pre -ovula tory as opposed to 63.6% in phase I. Laufer, de Cher-
ney, Haseltine et al (1983) reported recovery of 42% mature and 
49 % intermediate eggs (based on the morphological appearance of 
the oocyte-corona-cumulus complex) in hMG-stimulated cycles with 
daily ultrasound scans. Cleavage rates in our series were 85.7 % 
and 73 . 1% of pre-ovulatory eggs in phase I and II respectively. 
This was comparable to 80.1 % cleavage rate in tubal obstruction 
reporte d by Mahadevan, Trounson, Leeton et al (1983), and to 68% 
for ma ture eggs and 79 % for intermediate eggs in the series of 
tuba l disease of Laufer, de Cherney, Haseltine and co-workers 
(1983). The improved pregnancy rate in phase II was probably a 
refl e ction of multiple embryo replacement (1.1 embryos per re-
Pla c eme nt in pha s e I and 2 .3 embryos per replacement in phase 
tx) • 
u n 
. s f or follicles interfere with urine col-
ultr son1c sc n 
f de
t ec tion of spontaneous LH surge); timing 
( n c ss ry or 
ri bl wi h xc si ve urine volumes . The latter was a 
) . h 
Hi-Gon 
. s used to monitor for spontaneous 
VlS W 
r , th 
y 
ur s occur more commonly in 
n 
r r y i n hMG- lone cycles for IVF (see 
i 
f or LH is not necessary for 
monitor g 
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hMG-alone cyc l e s. It is possible to circumve nt the high urine 
output by mea suring blood LH, but this requires more venepunc-
t ures or an indwe lling dannula. 
Another possible disadvantage of r e peated ultrasonic scan is 
Ultrasound - induc ed da ma ge to eggs d uring meiotic reactivation 
(Edwards , 1984) . Howe v e r, ultrasonically-guided egg recovery has 
been pra ctised since 1981 (Lenz, Lauritsen and Kjellow, 1981 ). 
nece ntly the r e has been some reports of pregnancies with this 
technique (Wikla nd , Nil sson , Hansson et al, 1983; see Seppala, 
1895) a nd many norma l de l i v e ri e s have occurred without being 
teporte d ye t in the li t e r a ture . In addition to pregnancies from 
ttans ve si ca l a spiration, the transvaginal route has also been 
successful ( Delle nbach , Nisa nd , Moreau e t al, 1984). Caution is 
al s o d v is d wi th r e g rds t o ul tra sound scans for follicular 
~atu rity b c us e pr ema ture rupture o f mature follicles has been 
t ePort ( T s t r t , The ba ult and Frydman, 1982a). 
n hi . t he ultrasound sca n f r e que ncy to once-a-
s s u y , r uc~ ng 
cycl 
no 
accur 
cy r 
inim l 1 
one 
y 
t ~ 
wo 
l'ty I n fact, it improved the 
o mpromise egg qu a ~ • 
un r 
o n 
in 
hose c i rcumst nces . Fol lowi ng tha t study 
nnin 
rri 
for the r e st of phase II , u s ua lly 
It must be noted tha t a t t hat 
ou . 
i not s can their pa t ient s c n r s 
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fr e que ntly : Bourn Hall clinic (Edwards, Steptoe and Purdy, 1980) 
a nd Monash University (Buttery, Trounson, McMaster et al, 1983). 
Howev e r, when we sta rted on the FSH-hMG (Me trodin-Pergonal) com-
bina tion we f ound that E2 alone was inadequate to monitor the 
Prog r e ss o f such cycles, mainly because the number of follicles 
We r e much more in excess of patients stimulated with clomiphene-
hMG . For this current st imulation regime, ultrasound scans are 
done once e very other day from day 7 until the follicles reach 
a bout 14 mm in diame t e r, when the scans are repeated daily until 
egg recovery . 
Dltrasound assessment of f ollicular growth is useful in identify-
ing the ovary in which the f ollicle(s) may be developing. This is 
important fo r centres where the r e are no facilities for 
Ultr sonic-guided aspiration of follicl e s . Under such cir-
~Umst nces , it is useful to identi f y pa t ients in whom one ovary 
lllay b co r by hesions . 
It a l s o helps clarify the response 
ta 
s imul tion n 
m y ass ist in decid ing the optimal time to 
harmon l 
ss ys . Kerin , Edmonds , Wa rne s et al (1981) con-
h i m 
on 0 r 
ou nno b 
mm for the largest f ollicle was a n r of 12 
hermon l monitoring . 
u s th 
sole monitor to d e t e rmine the 
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time of injection of hCG because by itself ultrasound does not 
adequate ly assess the functional capacity of the follicles 
(Trounson , 1982) . Also , though the presence of a cumulus on 
ultrasound has been reported to be reliable (Hackeloer and 
Hansma nn, 1983) , other workers have found its presence unreliable 
(Nitschke-Dabelstein , 1983) . However , they have been some reports 
on the r e liance of ultrasound scans to determine follicle 
matur i t y a nd timing of hCG , based mainly on the echogenecity of 
the e nd ome trium (Smith , Porter , Craft et al , 1984) 
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TABLE 9 . 1 : MEDIAN VALUES OF AVERAGE FOLLICLE DIAMETERS (em) IN 
CLOMIPHENE-INDUCED AND UNSTIMULATED CYCLES 
Days before laparoscopy Follicle 
numbers -------------------------------------- n r 
----
-7 
~miphene 
One 1 • 20 
'l'wo 1 • 1 3 
1'hree 
Pive 
~ 
On 
'l'wo 
n -
t 
----------
m 0 
m 1 ' 
-6 -5 -4 -3 -2 -1 0 
1 • 40 1. 60 1. 93 2.17 2 . 23 2 . 33 2 . 27 7 0 . 976 
1 . 20 1. 37 1. 47 1. 72 1. 90 2 . 10 2 . 02 12 0 . 976 
1. 60 1 • 68 2 . 00 1. 80 6 0 . 800 
0 . 90 - 1. 20 1. 20 1. 53 1. 37 1. 25 5 0 . 753 
1 • 1 4 1. 29 1. 52 1 • 93 2 1 • 000 0 . 97 
1 • 23 1. 39 1. 50 1. 78 1. 57 10 0 . 250 1 • 2 . 23 
---------------------------
--- --
-----
-------- --
o llicl s 
orr l ·on co fficie nt 
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FIGURE 9.1: ESTRADIOL VALUES IN CLOMIPHENE-HMG INDUCED PATIENTS 
WHEN SPONTANEOUS LUTEINIZING HORMONE SURGE OCCURRED. 
P L AS ~1A 
lJESTRAD IOL ( pg/m l) 
AT HI CH 
SPO T A EOUS 
L . H. OCCURRED 
(Y ) 
oou 
* 
* * 
ouo 
2uuu 
uuu L--L-----lr----\----~------l~6---77-NUMBER OF 
l 3 5 FOLLICLES 
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ON DAY 9 BY 
ULTRASOUND 
(X ) 
CHAPTER 10 
LUTEAL PHASE MANAGEMENT 
§X.NOPSIS 
!t has been previously postulated that the luteal phase in IVF 
cycles needed hormonal support because follicular aspiration 
t esulted in less luteal cells , with lower P levels . This chapter 
Ptesents data from a double-blind randomized trial in which 
either p ( 25 mg dai ly i . m. from the second day after laparoscopic 
tecove ry ) or placebo {vitamin B complex 1 ml ) were administered 
in the lute 1 phase . There we re 22 patients in the P group , and 
~ 1 P i n s in the placebo group . There were 5 pregnancies in the 
r oup , nd 3 pre gnancies in the latter group . There was no 
St t is ic 1 if r e nee ( p>O . OS) in the luteal phase E2 values be-
t~ en h 2 r o ups , e ve n fter separating the data for spon-
t n o 
s LH r n hCG dministration. However , there was a 
c i r nee {p<0 . 02 ) in the plasma P on days 10 and 
2' wt n h n t i n th placebo g roup had lower plasma P , 
w on rib t m inly by p tien ts who had spontaneous 
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LH. Luteal phase duration was significantly shorter in the 
placebo group as menses was prevented from coming in the p group 
(13 . 0 days and 14 . 8 days respectively, p<0 . 001 ). Higher E2 levels 
on the day before laparoscopic egg recovery did not shorten the 
luteal phase . 
INTRODUCTION 
The corpus luteum is intimately dependent on pre-ovulatory fol-
licular development . After extrusion of the egg , capillaries from 
the thecal layers invade the granulosa cell layer and fill the 
former antral cavity with blood . Cholesterol transported by low 
density lipoproteins is thus allowed to reach the granulosa cells 
to augment progesterone production (Carr, MacDonald and Simpson, 
1982) . Early luteal function is dependent on basal levels of LH . 
This is classically seen in ovulation induction in 
hypogonadotropic hypogonadic patients , who exhibit shortened 
luteal phases when a single LH dose was administered for the pre-
0Vul tory gonadotropin surge, but when hCG or repeated LH doses 
~ere given the re was basal gonadotropic support of the corpus 
luteum (Jewelwicz , Dyrenfurth , Warren et al, 1973) . 
~ secretion ff cts both the ovarian and endometrial development. 
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Togethe r with E2 , P exerts a nega tive fe edback on gonadotropin 
secre tion . New fo l licu l ar deve lopment is further suppressed by 
antagonism of E2 dependent mitogenic effects of other follicl e s. 
McNatty , Hilli e r , van der Boogaard, et al (1983) reported that 
9
4% of lutea l phase folli cle s greater than 1 mm in diameter were 
atretic (a s determined by oocy t e viability and granulosa cell 
numbers ) . Goodma n a nd Hodgen (1977, 1979) noted that ov ulation 
Occurred in monke ys in the cont r a l a t e ral ovary in about 70 % of 
the ti me i n nor ma l menstrual cycles. Also, regardless of the site 
Of the fo r me r co rpus lute um , the subsequent dominant follicle 
develops in the ovary which prod uced the lowest amount of P into 
the Ve nous system duri ng the antecedent luteal phase (diZerega 
and H 
o gen , 1 982 ) . 
de v 1 
e opment of the 
et 
licl 
Hence , intralutea l P a f f ects the future 
fol l ic l e . Howeve r Bai rd, Backstrom, McNeilly 
that the absence of healthy antral fol-1 (1 98 ) r porte 
es in th Wa s due t o inhibitory effects of the 1 te 1 ph se 
d that the s uppr e ssion of m. Th y postula t e 
9ona 
otropins i 
! 
teum . 
by 0 . t 01·ds secr eted by the corpus rl n s e r 
y 
h 
hcG from t he de veloping r ovul tion , 
corpus l ute um . A 2-week pr olonga tion 
n ( nd hence , the menstrual cycle) 
e xogenous hCG i njecti ons a p-1 y with 
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Proximate ly 8 -10 days after ovulation (Quagliarello, Goldsmith 
I 
Steine tz , e t a l , 1980) . Since hCG alone cannot simulate pregnancy 
mainte na nce o f the corpus luteum beyond this 2-week interval I 
Othe r intrinsic factors may be present . Furthermore, it is known 
that the sensitivity of the corpus luteum to LH/hCG stimulation 
Prog r e ss i v e l y decreases as a non-steroidal LH receptor binding 
inhi b ito r ( LHRB I) increases (Cha nning, Anderson , Hoover, et al, 
1982) . p secre tion in vitro can be inhibited by LHRBI. Main-
tena nce of the corpus luteum in early pregnancy may result from a 
non- hc G me i t ed ntagonism of the effect of LHRBI. 
p support in the luteal phase is controversial . Work with 
Pr· l.mates sug t 
·sed p production in a third of them 
es c omprom1 . 
( ~ teitm n n , . d H den 1981 ). However , clinical studies 1xon a n o g ' 
have 
no b n convincing (Feichtinger , Kemeter , Szalay et al, 
1982 · 
1 G r 
t e t al 1981 ). Yovich has reported the 
, Jon s , Acos a ' 
\.ls 
0 s t e rone acetate 
(Yovich, Puzey, de'Atta 
o r 1 m r o xypro 
E!t l , Stanger , Yovich et 
al 1984b). 
82 ) hC ( Yovich , 
fio~,~ 
0 no t g ive such 
therapy (Trounson and 
n r 
loloo t hiS chapter was 
to study the dif-
I 1 8 ) . T rpo s of 
fer pl c e bo support in the luteal 
c po r n u 
Ph s 
0 'mul t 
with clomiphene-hMG. 
F n 
1 8 4 
Pat ients wer from ph a se I I o f t he IVF program . The stimulation 
on~toring h v e b e e n describe d in chapter 3 . ana m . 
Fol low · ~ ng 1 pa r oscopic egg r e cove ry, the patients were randomized 
study into 2 g roups : one group was given i . m. p 
in a o u bl e - bli n 
the 2nd post -re covery day until the 14th post-
25 rng aily rom 
a , a n the o the r g roup was given i . m. vitamin B com-
Pl e x . . ~n)ectio n 1 ml ( plac e bo group) f or the same duration . The 
recove r 
injec t . ~on s r e covered a nd n e i the r the patient nor the nurse 
the i n jection k n e w wha t was a dmin>stered . The code was 9iving . 
f t e r the o utcome o f the treatment was known . There 
22 
pa tient s in the P group, and 21 patients in the 
brok en o nl y 
o t 1 0 
Placeb 0 g r o u p . 
Ser um w s 
jec · l.on s 
sa rn l p s w r 
foll o w i n 
p i n w r 
i c 1 
k n o nce e very 2 days i n the morning before the in-
r in from the daY o f l a p a roscopic egg recovery. The 
a n a na lysed together. After the 10th day 
co 1 ct 
P r oscopic e gg col l ec tion , the values from pregnant 
no t included i n the a na lysis . 
by 
t h e s t udent's t-test . 
ly iS W S 
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RESULTS 
The plasma E2 results are given in table 10.1. The E2 level for 
the group given Prose from a mean of 777.3 pg/ml on the day of 
egg collection to 1451.1 pg/ml on the 4th day after the recovery 
(day 4). It then declined to 105.4 pg/ml on day 14. The E2 values 
for placebo group were similar, but with a gentler decline on day 
6 and day 8. However, there were no statistical difference be-
tween the 2 groups (p>0.05). 
Plasma P values are given in table 10.2. As with E2 , P values in-
creased from 14.1 and 21.7 ng/ml on the day of collection to a 
maximum on day 4 (56.4 and 53.5 ng/ml for the P and placebo group 
respectively). There was no statistical difference between the 2 
groups in the first 8 days although the plasma P was slightly 
lower in the former group inspite of exogenous P (except day 4). 
However , on the 10th and 12th day, the plasma P was significantly 
higher in the p group (p<0.02); on the 14th day, it was also 
higher but this was not significant (p>0.05). There was an ex-
tremely high p value of 86.6 ng/ml on day 14 in the P group 
Without pre gnancy and this value was excluded in the analysis. 
When spontaneous LH surge cases were analysed separately from the 
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hCG patients, there was no statistical differences in plasma E2 
for the groups given P or placebo (tables 10.3 and 10.4). There 
was similiarly no difference in the plasma P (tables 10.5 and 
10.6) except for the spontaneous LH group where plasma P was sig-
nificantly lower in days 10, 12 and 14. 
Plasma P values also did not differ significantly (p>0.05) when 
the hCG subgroup was compared with the spontaneous LH subgroup 
for both the groups given P or placebo. 
Treatment with either P or placebo did however significantly af-
fect the luteal phase duration (table 10.7). Menses was prevented 
until a mean of 14.8 days after egg recovery in the P group, 
after the p was stopped. In the placebo group, the luteal phase 
length of 13.0 days was shorter (p < 0.001). To check whether 
higher pre-recovery E2 resulted in a shorter luteal phase, the 
data was analysed with E2 values on the day before laparoscopic 
egg recovery at 2000 pg/ml or less, and above 2000 pg/ml. There 
Was no significant shortening (p>0.05) of the luteal period in 
both the p and the placebo groups (table 10.7). 
There were 5 pregnancies in the P group (1 biochemical, 2 abor-
tions, and 2 full-term pregnancies), and 3 pregnancies in the 
Placebo group (1 abortion and 2 full-term pregnancies). The num-
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ber of pregnancies were too small for meaningful statistical 
analysis, but there is no obvious advantage in P therapy in so 
far as pregnancies were concerned. 
~ISCUSSION 
In the series of 43 patients stimulated with clomiphene-hMG, 
there was an artificial prolongation of luteal phase duration in 
the supported group because of P administration until the 14th 
day after laparoscopic egg recovery. In the placebo group, the 
duration was only 13.0 ~1.4 days. This was much shorter than the 
mean of 15.5 +2.3 days reported for clomiphene-hMG cycles 
Without luteal phase support (Cohen, Debauche, Pigeau et al, 
1984) and the mean of 15.1 +1.4 days reported for hMG-stimulated 
IVF cycles without luteal phase supplementation by Garcia, 
Jones, Acosta et al (1981). However, the values were equivalent 
to the mean of 13.5 ~1.3 days reported for unstimulated IVF 
cycles by Feitchtinger , Kemeter, Szalay et al (1982) and 12.3 + 
3.5 days for the non-aspirated controls reported by Garcia, 
Jones, Acosta et al . Clomiphene-induced cycles were reported to 
have normal luteal function (Trotnow, Becker, Kniewald et al, 
1982; Kerin, Warnes , Quinn et al; 1983a). 
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In our series, the maximum mean P value for the placebo group was 
on the fourth day after the laparoscopy (53.5 ng/ml ~31.2). This 
corresponded to the report of Gronow, Martin, Hay et al (1985) 
where they monitored 55 patients through the luteal phase with 
plasma E2 and pregnanediol glucoronide every other day; both con-
ceptual (11 pregnancies) and non-conceptual cycles showed a peak 
in pregnanediol glucoronide level around luteal day 6; the level 
then fell and was "rescued" if there was an implanting embryo. In 
Garcia, Jones, Acosta et al 's (1981) series, the maximum P value 
was around 19 ng/ml on the 7th day after laparoscopy for the 
hMG-stimulated IVF cycles without luteal phase supplementation. 
There was no luteal phase defects in this group. The gross dif-
ference in P values cannot be explained by the different stimula-
tion regimes. In a report on 13 women stimulated with clomiphene 
citrate, Oskowitz, Seibel, Smith et al (1986) found that there 
Was no difference in mean P levels in the group of women who had 
follicular aspiration , compared to the control group (no 
aspiration) . They also found that in the first luteal week, the 
clomiphene group had higher levels of P, compared to an unstimu-
lated group; in the second week P levels were similar. Our data 
also showed no demonstrable luteal phase deficiency in the 
Placebo group . In their study of 32 non-stimulated cycles, Feich-
tinger, Kemeter, Szalay et al (1982) reported a deficiency of the 
luteal phase in 2 cases . 
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A mature Graafian follicle has about 50 * 106 granulosa cells 
(McNatty, Smith, Makris et al, 1979). On follicular aspiration , 
an average of 3 * 10 6 are removed (Jones, Garcia and Acosta, 
1981 ); this is less than 10% of the total content. However, the 
authors reported that in 9 spontaneous cycles (with LH surge), 
multiple vigorous aspirations were done in a futile effort to ob-
tain oocytes; the level of P in the luteal phase in these 
patients were significantly less than the controls (where no 
laparoscopy wa~ done). 
In the P group, the length of the luteal phase (14.8 ~0.7 days) 
was much shorter than a similar group reported by Garcia, Jones, 
Acosta et al (1981) (19.6 ~3.9 days). This may be due to con-
tinued P injections. Unfortunately, the authors did not specify 
the duration of the luteal phase support, and it is not possible 
to interprete the data on luteal phase length. However, their 
reported group of 8 patients with luteal phase support included 
one patient who was given hCG. Yovich, Stanger, Yovich et al 
(1984b) reported that hCG promotes a longer luteal phase duration 
than medroxyprogesterone acetate. In a controlled trial with 
intramuscular 17-0H progesterone caprioate (Proluton), Leeton, 
Trounson and Jessup (1985) reported that there was no increase in 
Pregnancy rates with Proluton; there was no data on luteal phase 
190 
length or hormonal levels in that report. The maximum mean p 
value in P-supported group in the present study was 56.4 {~24.1) 
ng/ml on the 4th day following laparoscopy, whereas for Garcia, 
Jones, Acosta et al's (1981) series the maximum mean value was 
around 21 ng/ml on the 8th day. 
Estrogen administered early in the luteal phase increases the 
ratio of prostaglandin F to prostaglandin E (Balmaceda, Asch, 
Fernandez et al, 1980), an event occurring physiologically late 
in the luteal phase {Balmaceda, Valenzuela, Eddy et al, 1980). It 
has also been reported that prostaglandin F2a inhibits P produc-
tion while prostaglandin E2 stimulates P synthesis {Sotrel, Hel-
vacioglu, Dowers, et al, 1981; Peters and McNatty, 1980). It is 
Possible that luteal E2 fosters the decline of the corpus luteum 
via alteration of this prostaglandin balance. This is seen clini-
cally when the follicular E2 levels rise excessively after 
stimulation (Olson, Rebar, Schreiber et al, 1983). However, in 
the small series of the present study, there was no shortening of 
luteal phase duration when the pre-recovery E2 was high (above 
2000 pg/ml). Since hCG inhibits prostaglandin synthesis 
(Balmaceda, Asch, Fernandez et al, 1981 ), the elevation of pros-
taglandin F
2
:prostaglandin E may be prevented in the corpus 
luteum by the intervening pregnancy. 
1 91 
In this study it was demonstrated that there was no difference in 
E2 levels in the luteal phase. This was also reported for hMG-
stimulated patients (Muasher, Acosta, Garcia et al, 1984). They 
reported that the mean E2 and P during the luteal pahse showed no 
statistically significant difference between the pregnant and 
non-pregnant patients except after day 11. The mean serum E2 in 
most of the luteal phase days was highest in the high responders 
followed by the normal and low responders. 
There was a significantly higher plasma P in the P supported 
group on days 10, 12 and 14. This was seen only in the patients 
with spontaneous LH surges, and not after hCG injection. There 
was also no significant improvement in pregnancy rates with p 
support. Hence, there was no advantage in giving P. However, it 
has been reported by Jones (1983) that their stimulation with 
gonadotropins has to be complemented with P or hCG in the luteal 
phase because endogenous LH production is not sufficient for the 
high number of receptor sites. 
Changes in luteal phase endometrium after stimulation with 
clomiphene-hMG has been reported by Cohen, Debauche, Pigeau et al 
(1984). In 19 cycles where no embryo replacement was done due to 
adhesions preventing puncture, infected or insufficient sperms, 
failure of fertilization, or failure of cleavage, 7 were within 
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normal limits, 8 were hypotrophic (with inability to maintain 
nidation), and 4 were intermediate. When the endometrial quality 
biopsi e d on the third day after laparoscopy was compared with 
estradiol and progesterone on the same day in 12 cases, highly 
Variable steroid levels were observed in both competent and in-
competent endometrium . Hence it is not possible to predict the 
state of the endometrium on steroid levels alone. In another 
study with clomiphene-stimulated cycles (Frydman, Testart, 
Giacomini et al, 1982), histologic parameters coincided with the 
luteal phase day, in contrast to spontaneous cycles where 24% of 
the cases who had endometrial biopsies had dystrophic en-
dometrium. Abate , Call and Stanchi (1984) reported that en-
dometrial biposy done at the time of embryo replacement had no 
effect on pregnancy results; pregnancy rate was highest when the 
endometrial histology had a 17th or 18th day pattern. However, on 
Ultrasonography in the periovulatory phase, there was a better 
chance of implantation if the endometrium was thick (Glissant, de 
Mouzon and Frydman , 1985). Interestingly too, they found no cor-
relation between the thickness of the endometrium and follicle 
numbers; the same conclusion was also found for hormonal levels. 
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TABLE 10.1: PLASMA ESTRADIOL LEVELS (pg/ml) IN THE LUTEAL PERIOD 
WITH PROGESTERONE SUPPORT OR PLACEBO TREATMENT 
Days after egg recovery 
0 2 4 6 8 10 
Progesterone 
Mean 
so. 
n 
Placebo 
Mean 
so. 
n 
777.3 1198.0 1451.1 1101.1 610.7 247.8 
536.3 1056.3 1160.0 780.5 536.1 213.5 
22 22 22 22 22 1 7 
691.3 1119.6 1531.7 1438.8 890.0 278.4 
427.9 678.2 1178.6 981.6 554.7 109.3 
21 21 21 21 21 18 
12 
126.3 
41 • 3 
17 
1 45. 1 
70.9 
14 
1 4 
105.4 
18.2 
15 
109.0 
34.2 
4 
---------------------------------------------------------------
P values were not significant on all days (p>0.05) 
194 
TABLE 10.2: PLASMA PROGESTERONE LEVELS (ng/ml) IN THE LUTEAL 
PERIOD WITH PROGESTERONE SUPPORT OR PLACEBO TREATMENT 
Days after egg recovery 
-------------------------------------
0 2 4 
hoqesterone 
Mean 
SD. 
n 
R._lacebo 
Mean 
SD. 
n 
p 
1 4. 1 
0.0 
22 
38.4 
17.0 
22 
56.4 
24. 1 
22 
21.7 43 .0 53.5 
38.3 25.6 30.3 
21 21 21 
ns ns ns 
6 
43.9 
22.3 
22 
52.1 
23.7 
21 
ns 
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8 
25.6 
25.1 
22 
28.4 
1 7. 3 
21 
ns 
1 0 
15.5 
10.2 
1 7 
12 
11 • 1 
5.6 
1 7 
14 
12.0 
4.9 
15 
8.6 5.2 7.6 
4.0 5.1 8.2 
18 14 4 
<0.02 <0.01 ns 
TABLE 10.3 PLASMA ESTRADIOL LEVELS (pg/ml} IN THE LUTEAL PERIOD 
FOLLOWING HCG INJECTIONS WITH PROGESTERONE SUPPORT OR 
PLACEBO TREATMENT 
Days after egg recovery 
0 2 4 6 8 1 0 1 2 
Progesterone 
Mean 855.7 1438.5 1725.1 1303.9 707.1 258.4 136.7 
SD. 
n 
Placebo 
564.6 1182.7 1314.7 829.8 600.9 249.3 
1 5 1 5 15 1 5 15 12 
42.6 
12 
• 
1 4 
98.5 
33.3 
1 0 
Mean 795.0 1439.5 2054.5 1879.4 1170.2 286.2 141.7 135.5 
so. 523.0 727.2 1279.5 1024.6 574.5 109.7 
n 12 1 2 1 2 1 2 1 2 9 
65.3 
8 
26.2 
2 
---------------------------------------------------------------
P values were not significant on all days (p>O.OS) 
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TABLE 10.4: PLASMA ESTRADIOL LEVELS (pg/ml) IN THE LUTEAL PERIOD 
FOLLOWING SPONTANEOUS L.H. SURGE WITH PROGESTERONE SUPPORT 
OR PLACEBO TREATMENT 
0 
R_rogesterone 
Mean 
SD. 
n 
R._lacebo 
Mean 
SD . 
n 
666.4 
395.8 
7 
51 5 . 1 
1 40 . 2 
9 
Days after egg recovery 
2 
682.8 
432.7 
7 
693 .0 
253.9 
9 
4 6 8 
719.9 666.4 404 .1 
378 .7 449 .8 300.5 
7 7 7 
834.7 
520.9 
9 
851 .2 
534 . 2 
9 
51 6 . 4 
2 01 • 6 
9 
10 
222.4 
1 01 • 4 
5 
270.6 
11 5. 0 
9 
1 2 
1 01 • 4 
26.9 
5 
149.5 
84.0 
6 
1 4 
101.0 
22.2 
5 
82.5 
3 . 5 
2 
--------------------------------------------------------------
P values were not significant on all days (p>0.05} 
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TABLE 10.5: PLASMA PROGESTERONE LEVELS {ng/ml) IN THE LUTEAL 
PERIOD FOLLOWING HCG INJECTIONS WITH PROGESTERONE SUPPORT OR 
PLACEBO TREATMENT 
0 
R_rogesterone 
Mean 
so. 
n 
R_lacebo 
Mean 
so. 
n 
17.2 
1 0. 6 
1 5 
28.7 
48 .3 
1 2 
Days after egg recovery 
2 
44.9 
17.0 
1 5 
54.6 
27.0 
1 2 
4 
65.6 
22.8 
1 5 
66.9 
33.4 
1 2 
6 
so. 1 
23.3 
15 
62.1 
24.9 
1 2 
8 
34.6 
29.2 
15 
36.5 
1 7. 3 
12 
1 0 
16.5 
11 • 9 
12 
9.2 
4.3 
9 
1 2 
11 • 4 
6.3 
12 
6. 1 
6.7 
8 
1 4 
12.7 
5.5 
1 0 
11 • 0 
12.2 
2 
-------- --------------------------------------------------------
P values were not significant on all days (p>0.05) 
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TABLE 10.6: PLASMA PROGESTERONE LEVELS (ng/ml} IN THE LUTEAL 
PERIOD FOLLOWING SPONTANEOUS L.H. SURGE WITH PROGESTERONE 
SUPPORT OR PLACEBO TREATMENT 
0 
R._rogesterone 
Mean 
so. 
n 
R._lacebo 
Mean 
so. 
n 
p 
7.4 
3.4 
7 
12.2 
1 0. 0 
9 
ns 
Days after egg recovery 
2 
25.4 
6.7 
7 
27.5 
12.8 
9 
ns 
4 
36.7 
12.4 
7 
37.1 
14.7 
9 
ns 
6 
30.8 
13.5 
7 
38.8 
14.4 
9 
ns 
1 99 
8 
18.9 
4.9 
7 
17.5 
1 0. 2 
9 
ns 
1 0 
12.9 
3.7 
5 
8. 1 
3.8 
9 
12 
10.2 
4. 1 
5 
4.0 
1.3 
6 
1 4 
10.3 
0. 1 
4 
4.3 
3.0 
2 
p<0.05 p<0.01 p<0.01 
TABLE 10.7: LUTEAL PHASE DURATION 
* Treatment with progesterone 
* Treatment with placebo 
Estradiol before egg recovery+ 
Treatment with progesterone 
< 2000 pg/ml 
) 2000 pg/ml 
Treatment with placebo 
< 2000 pg/ml 
) 2000 pg/ml 
* + p<0.001; p = n.s. 
2 0 0 
. 
. 
14.8 +0.7 days 
13.0 +1.4 days 
1 4. 5 + 1 • 0 days 
15.0 +0.0 days 
13.2 +1. 6 days 
12.8 + 1 • 2 days 
CHApTER 11: 
CONCLUSION 
Base d on the information analysed , the following overall conclu-
sions can be drawn : 
1 • The mean follicular phase E2 levels per follicle in the 
unstimulated and stimulated patients (clomiphene and 
clomiphene-hMG) were similiar. 
~ . There were more follicles seen on ultrasound with the 
clomiphene-hMG stimulation , though there was no difference 
in administering 1 or 2 ampoules/day from days 6 to 8. 
3. Though there were more pre-ovulatory eggs collected when the 
hCG was given earlier , the fertilization and cleavage rates 
were reduced . However, this effect was probably due to the 
higher incidence of spontaneous LH surge when hCG was 
delayed because there was no statistical difference in the 
egg quality and fertilization when the patients with spon-
taneous LH surge were excluded . 
4
• Spontaneous LH surge measured with Hi-Gonavis had a high false 
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negative (7.4%) and a high false positive (16.7 %) rate. 
However, the true positive group had less mature eggs and 
poorer fertilization rate; this may be due to absence of 
hCG. It is therefore advisable to administer hCG regardless 
of spontaneous LH surge. 
5. It was not necessary to do repeated ultrasound scans if daily 
E2 results were available; it was also possible to predict 
when the spontaneous LH was likely to occur based on the E2 
levels and the number of follicles. 
6. When the luteal phase was supported with daily intramuscular 
P, there were significantly higher plasma levels of P on 
days 10 and 12, seen when there was spontaneous LH. As ex-
pected the placebo group had a shorter luteal duration (13.0 
days, compared to 14.8 days in the P-supported group); 
however, there was no markedly low P levels in the placebo 
group . 
I wish to emphasize that all the endocrine manipulation for over-
stimulation in IVF cycles can result in abnormalities not con-
ducive to the final outcome, i.e. to obtain a pregancy. Centres 
all over the world are trying to find a balance between stimula-
tion and optimal results. 
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We a r e far from this balance at the moment . Yuen , Pride, Rowe et 
al (1985) reported on a controlled trial with a low-dose 
II 
nonsuperovula tion" and a high-dose, individually adjusted 
"contro lled-supe rovulation" r e gimen with hMG in women with normal 
c y cle s. In the latter regimen , more hMG was used (19 . 8 versus 
10.3 ampoule s for the "controlled-superovulation" regimen and 
"nonsupe rovulation " regime respectively ), E2 levels were higher 
(1288 pg/ml ve rsus 343 pg/ml), more eggs were retrieved (53 
oocy t es f rom 18 cycles versus 25 oocytes from 11 cycles), and 
more e gg s we re mature (87 % versus 44% ) . Moreover , there were more 
eggs tha t f ertilized and cleaved ( 72% versus 52%) , with 2 preg-
na nci e s in 18 cycles in the "controlled-superovulation" regime 
(11 %) while there were no pregnancies in 11 cycles in the 
II 
nonsuperovulation" regime . The authors concluded tha t the 
highe r-dos e "controlled-superovulation" regime was better for 
IVF . 
Howeve r, as we understand more of the negative or detrimental ef-
f e cts o f supe rovualtion, there may be a swing towards the other 
ex treme . 
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II 
•••••• now that the optimal conditions for oocyte retrieval and 
fertilisation in vitro and for embryo culture and transfer are 
more clearly defined and standardised, it would be worth con-
sidering a return to the use of natural unstimulated cycles. Al-
though they only yield a single oocyte they do so within a more 
Physiological endocrine environment." 
Jeffcoate SL (1985) 
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